National Academies Press: OpenBook
« Previous: 9 Conclusions and Recommendations
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

References

Abbott, B.D., and L.S. Birnbaum. 1990. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol. 106(3):418-432.

Abbott, B.D., J.J. Diliberto, and L.S. Birnbaum. 1989. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters embryonic palatal medial epithelial cell differentiation in vitro. Toxicol. Appl. Pharmacol. 100(1):119-131.

Abbott, B.D., M.W. Harris, and L.S. Birnbaum. 1992. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology 45(1):35-53.

Abbott, B.D., G.H. Perdew, and L.S. Birnbaum. 1994. Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol. Appl. Pharmacol. 126(1):16-25.

Abbott, B.D., M.R. Probst, G.H. Perdew, and A.R. Buckalew. 1998. AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology 58(2):30-43.

Abbott, B.D., G.A. Held, C.R. Wood, A.R. Buckalew, J.G. Brown, and J. Schmid. 1999a. AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicol. Sci. 47(1):62-75.

Abbott, B.D., J.E. Schmid, J.G. Brown, C.R. Wood, R.D. White, A.R. Buckalew, and G.A Held. 1999b. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Sci. 47(1):76-85.

Abel, E.A. 1995. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol. Teratol. 17(4):445-462.

Adams, M.D., et al. 2000. The genome sequence of Drosophila melanogaster. Science 287(5461):2185-2196.

Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994a. Dose-response assessment for developmental toxicity. III. Statistical models. Fundam. Appl. Toxicol. 23(4):496-509.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994b. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487-495.

Allen, B.C., P.L. Strong, C.J. Price, S.A. Hubbard, and G.P. Daston. 1996. Benchmark dose analysis of developmental toxicity in rats exposed to boric acid. Fundam. Appl. Toxicol. 32(2):194-204.

Alles, A.J., and K.K. Sulik. 1989. Retinoic-acid-induced limb-reduction defects: Perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology 40(2):163-171.

Alon, U., N. Barkai, D.A. Notterman, K. Gish, S. Ybarra, D. Mack, and A.J. Levine. 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 96(12):6745-6750.

Alonso-Aperte, E., N. Ubeda, M. Achon, J. Perez-Miguelsanz, and G. Varela-Moreiras. 1999. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 52(4):750-756.

Amsterdam, A., S. Burgess, G. Golling, W. Chen, Z. Sun, K. Townsend, S. Farrington, M. Haldi, and N. Hopkins. 1999. A large-scale insertional mutagenesis screen in zebrafish. Genes. Dev. 13(20):2713-2724.

Anderson, N.G., and L. Anderson. 1982. The Human Protein Index. Clin. Chem. 28(4 Pt. 2):739-748.

Anderson, N.L., and N.G. Anderson. 1998. Proteome and proteomics: New technologies, new concepts, and new words. Electrophoresis 19(11):1853-1861.

Andrews, J.E., M. Ebron-McCoy, U. Bojic, H. Nau, and R.J. Kavlock. 1995. Validation of an in vitro teratology system using chiral substances: Stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol. Appl. Pharmacol. 132(2):310-316.

Andrews, J.E., M.T. Ebron-McCoy, U. Bojic, H. Nau, and R.J. Kavlock. 1997. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture. Teratology 55(5):314-318.

Arman, E., R. Haffner-Krausz, Y. Chen, J.K. Heath, and P. Lonai. 1998. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. U.S.A 95(9):5082-5087.

Artavanis-Tsakonas, S., M.D. Rand, and R.J. Lake. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284(5415):770-776.


Baggs, R.B., R.K. Miller, and C.L. Odoroff. 1991. Carcinogenicity of diethylstilbestrol in the Wistar rat: effect of postnatal oral contraceptive steroids. Cancer Res. 51(12):3311-3315.

Bailey, A., A. Le Couteur, I. Gottesman, P. Bolton, E. Simonoff, E. Yuzda, and M. Rutter. 1995. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol. Med. 25(1):63-77.

Baker, N.E., and S.Y. Yu. 1997. Proneural function of neurogenic genes in the developing Drosophila eye. Curr. Biol. 7(2):122-132.

Baker, K., K.S. Warren, G. Yellen, and M.C. Fishman. 1997. Defective “pacemaker” current (Ih) in a zebrafish mutant with a slow heart rate. Proc. Natl. Acad. Sci. U.S.A. 94(9):4554-4559.

Baldwin, H.S., and M. Artman. 1998. Recent advances in cardiovascular development: Promise for the future. Cardiovasc. Res. 40(3):456-468.

Bantle, J.A., R.A. Finch, D.T. Burton, D.J. Fort, D.A. Dawson, G. Linder, J.R. Rayburn, M. Hull, M. Kumsher-King, A.M. Gaudet-Hull, and S.D. Turley. 1996. FETAX interlaboratory validation study: Phase III—Part 1 testing. J. Appl. Toxicol. 16(6):517-528.

Barber, C.V., and A.G. Fantel. 1993. The role of oxygenation in embryotoxic mechanisms of three bioreducible agents. Teratology 47(3):209-223.

Bargmann, C.I. 1998. Neurobiology of the Caenorhabditis elegans genome. Science 282(5396):2028-2033.

Bargmann, C.I., and I. Mori. 1997. Chemotaxis and termotaxis. Pp. 717-737 in C. elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Barker, D.J. 1999. Fetal origins of cardiovascular disease. Ann. Med. 31(Suppl. 1):3-6.

Barr, M., Jr. 1997. Growth as a manifestation of teratogenesis: Lessons from human fetal pathology. Reprod. Toxicol. 11(4):583-587.

Barth, L.G. 1939. The chemical nature of the amphibian organizer: III. Stimulation of the presumptive epidermis of ambystoma by means of cell extracts and chemical substances. Physiol. Zool. 12:22-29.

Battula, N., J. Sagara, and H.V. Gelboin. 1987. Expression of P1-450 and P3-450 DNA coding sequences as enzymatically active cytochromes P-450 in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 84(12):4073-4077.

Bayer, S.A., J. Altman, R.J. Russo, and X. Zhang. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14(1):83-144.

Beachy, P.A., M.K. Cooper, K.E. Young, D.P. von Kessler, W.J. Park, T.M. Hall, D.J. Leahy, and J.A. Porter. 1997. Multiple roles of cholesterol in hedgehog protein biogenesis and signaling. Cold Spring Harb. Symp. Quant. Biol. 62:191-204.

Becerra, J.E., M.J. Khoury, J.F. Cordero, and J.D. Erickson. 1990. Diabetes mellitus during pregnancy and risks for specific birth defects: A population-based case-control study. Pediatrics 85(1):1-9.

Bechter, R., G.D. Terlouw, M. Tsuchiya, T. Tsuchiya, and A. Kistler. 1992. Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture. Arch. Toxicol. 66(3):193-197.

Behringer, R.R., D.A. Crotty, V.M. Tennyson, R.L. Brinster, R.D. Palmiter, and D.J. Wolgemuth. 1993. Sequences 5' of the homeobox of the Hox-1.4 gene direct tissue-specific expression of lacZ during mouse development. Development 117(3):823-833.

Bellen, H.J. 1998. The fruit fly: A model organism to study the genetics of alcohol abuse and addiction? Cell 93(6):909-912.

Bellinger, D. 1994. Teratogen update: Lead. Teratology 50:367-373.

Best, J.B., and M. Morita. 1991. Toxicology of planarians. Hydrobiologia 227:375-383.

Binns, W., L. James, J.L. Shupe, and W.T. Huffman. 1963. A congenital cyclopian-type malformation in lambs induced by maternal ingestion of a range plant, Veratrum californicum. Am. J. Vet. Res. 24(103):1164-1175.

Blackwood, E.M., and J.T. Kadonaga. 1998. Going the distance: A current view of enhancer action. Science 281(5373):61-63.

Bladt, F., D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376(6543):768-771.

Bodey, B., B. Bodey, Jr., S.E. Siegel, and H.E. Kaiser. 1999. Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microenvironment. In Vivo 13(3):267-294.

Bojic, U., M.M. Elmazar, R.S. Hauck, and H. Nau. 1996. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect. Chem. Res. Toxicol. 9(5):866-870.

Bojic, U., K. Ehlers, U. Ellerbeck, C.L. Bacon, E. O’Driscoll, C. O’Connell, V. Berezin, A. Kawa, E. Lepekhin, E. Bock, C.M. Regan, and H. Nau. 1998. Studies on the teratogen pharmacophore of valproic acid analogues: Evidence of interactions at a hydrophobic centre. Eur. J. Pharmacol. 354(2-3):289-299.

Bostrom, H., K. Willetts, M. Pekny, P. Leveen, P. Lindahl, H. Hedstrand, M. Pekna, M. Hellstrom, S. Gebre-Medhin, M. Schalling, M. Nilsson, S. Kurland, J. Tornell, J.K. Heath, and C. Betsholtz. 1996. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85(6):863-873.

Bournias-Vardiabasis, N. 1990. Drosophila-melanogaster embryo cultures: An in vitro teratogen assay. ATLA, Altern. Lab. Anim. 18:291-300.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Brambilla, R., N. Gnesutta, L. Minichiello, G. White, A.J. Roylance, C.E. Herron, M. Ramsey, D.P. Wolfer, V. Cestari, C. Rossi-Arnaud, S.G. Grant, P.F. Chapman, H.P. Lipp, E. Sturani, and R. Klein. 1997. A role for the Ras signalling pathway in synaptic transmission and long- term memory. Nature 390(6657):281-286.

Brand-Saberi, B., and B. Christ. 1999. Genetic and epigenetic control of muscle development in vertebrates. Cell Tissue Res. 296(1):199-212.

Brandsma, A.E., D. Tibboel, I.M. Vulto, J.J. de Vijlder, A.A. Ten Have-Opbroek, and W.M. Wiersinga. 1994. Inhibition of T3-receptor binding by Nitrofen. Biochim. Biophys. Acta 1201(2):266-270.

Braun, A.G., C.A. Buckner, D.J. Emerson, and B.B. Nichinson. 1982. Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents. Proc. Natl. Acad. Sci. U.S.A. 79(6):2056-2060.

Brenner, S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71-94.

Brewster, R., and N. Dahmane. 1999. Getting ahead of the organizer: Anterior- posterior patterning of the forebrain. Bioessays 21(8):631-636.

Bridgeman, A.M., D. Buck, J. Burgess, W.D. Burrill, K.P. O’Brien, et al. 1999. The DNA sequence of human chromosome 22. Nature 402(6761):489-495.

Briggs, R., and T.J. King. 1952. Transplantation of living nuclei from blastula cells into enucleated frog eggs. Proc. Natl. Acad. Sci. U.S.A. 38:455-462.

Brockerhoff, S.E., J.B. Hurley, U. Janssen-Bienhold, S.C. Neuhauss, W. Driever, and J.E. Dowling. 1995. A behavioral screen for isolating zebrafish mutants with visual system defects. Proc. Natl. Acad. Sci. U.S.A. 92(23):10545-10549.

Brody, L.C., and B.B. Biesecker. 1998. Breast cancer susceptibility genes. BRCA1 and BRCA2. Medicine (Baltimore) 77(3):208-226.

Brown, D.L., K.R. Reuhl, S. Bormann, and J.E. Little. 1988. Effects of methyl mercury on the microtubule system of mouse lymphocytes. Toxicol. Appl. Pharmacol. 94(1):66-75.

Brown, J.R., H. Ye, R.T. Bronson, P. Dikkes, and M.E. Greenberg. 1996. A defect in nurturing in mice lacking the immediate early gene fosB. Cell 86(2):297-309.

Brown, N.A. 1987. Teratogenicity testing in vitro: Status of validation studies. [Review]. Arch. Toxicol. (Suppl.)11:105-114.

Brown, N.A., and S.J. Freeman. 1984. Alternative tests for teratogenicity. ATLA, Altern. Lab. Anim. 12(1):7-23.

Brown, N.A., M.E. Coakley, and D.O. Clarke. 1987. Pp. 17-31 in Approaches to Elucidate Mechanisms in Teratogenesis, F. Welsch, ed. Washington, DC: Hemisphere Pub.

Brown, N.A., J. Kao, and S. Fabro. 1980. Teratogenic potential of valproic acid. [letter]. Lancet 1(8169):660-661.

Brown, N.A., H. Spielmann, R. Bechter, O.P. Flint, S.J. Freeman, R.J. Jelinek, E. Koch, H. Nau, D.R. Newall, A.K. Palmer, J.Y. Renault, M.F. Repetto, R. Vogel, and R. Wiger. 1995. Screening chemicals for reproductive toxicity: The current alternatives: The report and recommendations of an ECVAM/ETS workshop (ECVAM Workshop 12). ATLA, Altern. Lab. Anim. 23(6):868-882.

Brown, P.O., and D. Botstein. 1999. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21(1 Suppl.):33-37.

Brunet, L.J., J.A. McMahon, A.P. McMahon, and R.M. Harland. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280(5368):1455-1457.

Bryson, S.E., and I.M. Smith. 1998. Epidemiology of autism: Prevalence, associated characteristics and implications for research and service delivery. MRDD Res. Rev. 4:97-103.

Bryson, S.E., B.S. Clark, and I.M. Smith. 1988. First report of a Canadian epidemiological study of autistic syndromes. J. Child Psychol. Psychiatry 29(4):433-445.

Buehler, B.A. 1984. Epoxide hydrolase activity and the fetal hydantoin syndrome. Proc. Greenwood Genet. Ctr. 3:109-110.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Buehler, B.A., D. Delimont, M. van Waes, and R.H. Finnell. 1990. Prenatal prediction of risk of the fetal hydantoin syndrome. N. Engl. J. Med. 322(22):1567-1572.

Bui, L.M., M.W. Taubeneck, J.F. Commisso, J.Y. Uriu-Hare, W.D. Faber, and C.L. Keen. 1998. Altered zinc metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acid. Toxicology 126(1):9-21.

Burbacher, T.M., P.M. Rodier, and B. Weiss. 1990. Methylmercury developmental neurotoxicity: A comparison of effects in humans and animals. Neurotoxicol. Teratol. 12(3):191-202.

Burke, A.C. 2000. Hox genes and the global patterning of the somitic mesoderm. Curr. Top. Dev. Biol. 47:155-181.


Cahill, G.M., M.W. Hurd, and M.M. Batchelor. 1998. Circadian rhythmicity in the locomotor activity of larval zebrafish. Neuroreport 9(15):3445-3449.

California Environmental Protection Agency. 1991. Draft Guidelines for Hazard Identification and Dose-Response Assessment of Agents Causing Developmental and/or Reproductive Toxicity. California Dept. of Health Services, Health Hazard Assessment Division. Reproductive and Cancer Hazard Assessment Section. April, 3.

Carney, E.W., A.B. Liberacki, M.J. Bartels, and W.J. Breslin. 1996. Identification of proximate toxicant for ethylene glycol developmental toxicity using rat whole embryo culture. Teratology 53(1):38-46.

Carpenter, E.M, J.M. Goddard, O. Chisaka, N.R. Manley, and M.R. Capecchi. 1993. Loss of HoxA1 (Hox-1.6) function results in the reorganization of the murine hindbrain. Development 118(4):1063-1075.

Cash, D.E., C.B. Bock, K. Schughart, E. Linney, and T.M. Underhill. 1997. Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: A modulator of chondrogenesis. J. Cell Biol. 136(2):445-457.

CDC (Centers for Disease Control). 1987. Table V. Estimated years of potential life lost before age 65 and cause-specific mortality, by cause of death-United States, 1985. MMWR 36(20):313.

CDC (Centers for Disease Control). 1995. Economic costs of birth defects and cerebral palsy-United States, 1992. MMWR 44:694-699.

C. elegans Sequencing Consortium. 1998. Genome sequence of the nematode C. elegans: A platform for investigating biology. Science 282(5396):2012-2018.

Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell Biol. 5(12):3403-3409.

Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10(9):940-954.

Chan, A.W., T. Dominko, C.M. Luetjens, E. Neuber, C. Martinovich, L. Hewitson, C.R. Simerly, and G.P. Schatten. 2000. Clonal propagation of primate offspring by embryo splitting. Science 287(5451):317-319.

Chang, C., D.R. Smith, V.S. Prasad, C.L. Sidman, D.W. Nebert, and A. Puga. 1993. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 3(6):312-321.

Chanut, F., and U. Heberlein. 1997. Role of decapentaplegic in initiation and progression of the morphogenetic furrow in the developing Drosophila retina. Development 124(2):559-567.

Chappell, P.E, J.P. Lydon, O.M. Conneely, B.W. O’Malley, and J.E. Levine. 1997. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology 138(10):4147-4152.

Chazaud, C., P. Chambon, and P. Dolle. 1999. Retinoic acid is required in the mouse embryo for left-right asymmetry determination and heart morphogenesis. Development 126(12):2589-2596.

Chen, J., A. Nachabah, C. Scherer, P. Ganju, A. Reith, R. Bronson, and H.E. Ruley. 1996. Germ-line inactivation of the murine Eck receptor tyrosine kinase by gene trap retroviral insertion. Oncogene 12(5):979-988.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Chervitz, S.A., L. Aravind, G. Sherlock, C.A. Ball, E.V. Koonin, S.S. Dwight, M.A. Harris, K. Dolinski, S. Mohr, T. Smith, S. Weng, J.M. Cherry, and D. Botstein. 1998. Comparison of the complete protein sets of worm and yeast: Orthology and divergence. Science 282(5396):2022-2028.

Chiang, C., Y. Litingtung, E. Lee, K.E. Young, J.L.Corden, H. Westphal, and P.A. Beachy. 1996. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 383:407-413.

Chisaka, O., T.S. Musci, and M.R. Capecchi. 1992. Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6. Nature 355(6360):516-520.

Chou, T.B., and N. Perrimon. 1996. The autosomal FLP-DFS technique for generating germline mosaics in Drosophila melanogaster. Genetics 144:1673-1679.

Christianson, A.L., N. Chesler, and J.G. Kromberg. 1994. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child Neurol. 36(4):361-369.

Chu, S., J. DeRisi, M. Eisen, J. Mulholland, D. Botstein, P.O. Brown, and I. Herskowitz. 1998. The transcriptional program of sporulation in budding yeast. Science 282(5389):699-705.

Clark, R.L., R.T. Robertson, D.H. Minsker, S.M. Cohen, D.J. Tocco, H.L. Allen, M.L. James, and D.L. Bokelman. 1984. Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits. Teratology 30(3):319-332.

Clarke, D.O., J.M. Duignan, and F. Welsch. 1992. 2-Methoxyacetic acid dosimetry-teratogenicity relationships in CD-1 mice exposed to 2-methoxyethanol. Toxicol. Appl. Pharmacol. 114(1):77-87.

Clarke, D.O., B.A. Elswick, F. Welsch, and R.B. Conolly. 1993. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: A physiological based mathematical model. Toxicol. Appl. Pharmacol. 121:239-252.

Clarkson, T.W. 1987. The role of biomarkers in reproductive and developmental toxicology. Environ. Health Perspect. 74:103-107.

Clarkson, T.W. 1993. Mercury: Major issues in environmental health. Environ. Health Perspect. 100:31-38.

Coberly, S., E. Lammer, and M. Alashari. 1996. Retinoic acid embryopathy: Case report and review of literature. Pediatr. Pathol. Lab. Med. 16(5):823-836.

Collins, F.S., A. Patrinos, E. Jordan, A. Chakravarti, R. Gesteland, and L. Walters. 1998. New goals for the U.S. Human Genome Project: 1998-2003. Science 282(5389):682-689.

Collins, M.D., and G.E. Mao. 1999. Teratology of retinoids. Annu. Rev. Pharmacol. Toxicol. 39:399-430.

Collins, T.F., R.L. Sprando, D.L. Hansen, M.E. Shackelford, and J.J. Welsh. 1998. Testing guidelines for evaluation of reproductive and developmental toxicity of food additives in females. Int. J. Toxicol. 17(3):299-325.

Colussi, P.A., and S. Kumar. 1999. Targeted disruption of caspase genes in mice: What they tell us about the functions of individual caspases in apoptosis. Immunol. Cell Biol. 77(1):58-63.

Colvin, J.S., B.A. Bohne, G.W. Harding, D.G. McEwen, and D.M. Ornitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12(4):390-397.

Conlon, R.A., and J. Rossant. 1992. Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo. Development 116(2):357-368.

Conlon, R.A., A.G. Reaume, and J. Rossant. 1995. Notch1 is required for the coordinate segmentation of somites. Development 121(5):1533-1545.

Cooper, M.K., J.A. Porter, K.E. Young, and P.A. Beachy. 1998. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280(5369):1603-1607.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Couture, L.A., B.D. Abbott, and L.S. Birnbaum. 1990. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Recent advances toward understanding the mechanism. Teratology 42(6):619-627.

Crabb, D.W. 1990. Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption. J. Clin. Invest. 85(2):311-315.

Crespi, C.L., and V.P. Miller. 1999. The use of heterologously expressed drug metabolizing enzymes—state of the art and prospects for the future. Pharmacol. Ther. 84(2):121-131.

Cresteil, T. 1998. Onset of xenobiotic metabolism in children: Toxicological implications. Food Addit. Contam. 15(Suppl.):45-51.

Crowley, C., S.D. Spencer, M.C. Nishimura, K.S. Chen, S. Pitts-Meek, M.P. Armanini, L.H. Ling, S.B. MacMahon, D.L. Shelton, A.D. Levinson, et al. 1994. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76(6):1001-1011.

Crump, K.S. 1984. An improved procedure for low-dose carcinogenic risk assessment from animal data. J. Environ. Pathol. Toxicol. Oncol. 5(4-5):339-348.

Cunha, G.R., J.G. Forsberg, R. Golden, A. Haney, T. Iguchi, R. Newbold, S. Swan, and W. Welshons. 1999. New approaches for estimating risk from exposure to diethylstilbestrol. Environ. Health Perspect. 107(Suppl. 4):625-630.

Cushnir, J.R., S. Naylor, J.H. Lamb, P.B. Farmer, N.A. Brown, and P.E. Mirkes. 1990. Identification of phosphoramide mustard/DNA adducts using tandem mass spectrometry. Rapid. Commun. Mass Spectrom. 4(10):410-414.


Dareste, M.C. 1877. La production artificielle des monstruosites. C. Reinwald et Cie, Paris.

Dasen, J.S., and M.G. Rosenfeld. 1999. Signaling mechanisms in pituitary morphogenesis and cell fate determination. Curr. Opin. Cell Biol. 11(6):669-677.

Daston, G.P. 1996. The theoretical and empirical case for in vitro developmental toxicity screens, and potential applications. Teratology 53(6):339-344.

Daston, G.P., and L.D. Lehman-McKeeman. 1996. Constitutive and induced metalothionein expression in development. Pp. 1139-1151 in Toxicology of Metals, L.W. Chang, ed. Boca Raton, FL: CRC Press.

Daston, G.P., G.J. Overmann, M.W. Taubeneck, L.D. Lehman-McKeeman, J.M. Rogers, and C.L. Keen. 1991a. The role of metallothionein induction and altered zinc status in maternally mediated developmental toxicity: Comparison of the effects of urethane and styrene in rats. Toxicol. Appl. Pharmacol. 110(3):450-463.

Daston, G.P., J.M. Rogers, D.J. Versteeg, T.D. Sabourin, D. Baines, and S.S. Marsh. 1991b. Interspecies comparisons of A/D ratios: A/D ratios are not constant across species. Fundam. Appl. Toxicol. 17(4):696-722.

Daston, G.P., G.J. Overmann, D. Baines, M.W. Taubeneck, L.D. Lehman-McKeeman, J.M. Rogers, and C.L. Keen. 1994. Altered Zn status by alpha-hederin in the pregnant rat and its relationship to adverse developmental outcome. Reprod. Toxicol. 8(1):15-24.

Daston, G.P., D. Baines, E. Elmore, M.P. Fitzgerald, and S. Sharma. 1995. Evaluation of chick embryo neural retina cell culture as a screen for developmental toxicants. Fundam. Appl. Toxicol. 26(2):203-210.

DeChiara, T.M., A. Efstratiadis, and E.J. Robertson. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345(6270):78-80.

Deng, C., M. Bedford, C. Li, X. Xu, X. Yang, J. Dunmore, and P. Leder. 1997. Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. Dev. Biol. 185(1):42-54.

DeSesso, J.M. 1979. Cell death and free radicals: A mechanism for hydroxyurea teratogenesis. Med. Hypotheses 5(9):937-951.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

DeSesso, J.M., and G.C. Goeringer. 1990. The nature of the embryo-protective interaction of propyl gallate with hydroxyurea. Reprod. Toxicol. 4(2):145-152.

DeSesso, J.M., and G.C. Goeringer. 1991. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits. Teratology 43(3):201-215.

DeSesso, J.M., and G.C. Goeringer. 1992. Methotrexate-induced developmental toxicity in rabbits is ameliorated by 1-(p-tosyl)-3,4,4-trimethylimidazolidine, a functional analog for tetrahydrofolate-mediated one-carbon transfer. Teratology 45(3):271-283.

DeSesso, J.M., A.R. Scialli, and G.C. Goeringer. 1994. D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits. Teratology 49(4):248-259.

Dickson, D. 1999. Gene estimate rises as US and UK discuss freedom of access. Nature 401(6751):311.

Downward, J., Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, and M.D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307(5951):521-527.

Dubnau, J., and T. Tully. 1998. Gene discovery in Drosophila: New insights for learning and memory. Annu. Rev. Neurosci. 21:407-444.

Duboule, D. 1998. Vertebrate hox gene regulation: Clustering and/or colinearity? Curr. Opin. Genet. Dev. 8(5):514-518.

Dudley, A.T., and E.J. Robertson. 1997. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev. Dyn. 208(3):349-362.

Duester, G. 1991. A hypothetical mechanism for fetal alcohol syndrome involving ethanol inhibition of retinoic acid synthesis at the alcohol dehydrogenase step. Alcohol Clin. Exp. Res. 15(3):568-572.

Dunham, I., N. Shimizu, B.A. Roe, S. Chissoe, A.R. Hunt, J.E. Collins, R. Bruskiewich, D.M. Beare, M. Clamp, L.J. Smink, R. Ainscough, J.P. Almeida, A. Babbage, C. Bagguley, J. Bailey, K. Barlow, K.N. Bates, O. Beasley, C.P. Bird, S. Blakey, Dupe, V., N.B. Ghyselinck, V. Thomazy, L. Nagy, P.J.A. Davies, P. Chambon, and M. Mark. 1999. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol. 208(1):30-43.

Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84(3):443-450.

Dwivedi, R.S., and P.M. Iannaccone. 1998. Effects of environmental chemicals on early development. Pp. 11-46 in Reproductive and Developmental Toxicology, K.S. Korach, ed. New York: Marcel Dekker.


Eastin, W.C., J.K. Haseman, J.F. Mahler, and J.R. Bucher. 1998. The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol. Pathol. 26(4):461-473.

Ebert, J.D., and M. Marois. 1976. Tests of Teratogenicity in Vitro: Proceedings of the International Conference on Tests of Teratogenicity In Vitro, Woods Hole, Mass., 1-4 April, 1975. New York: North-Holland Publishing Co.

Eckert, D., and M. Merchlinsky. 1999. Vaccinia virus-bacteriophage T7 expression vector for complementation analysis of late gene processes. J. Gen. Virol. 80(Pt. 6):1463-1469.

Edlund, T., and T.M. Jessell. 1999. Progression from extrinsic to intrinsic signaling in cell fate specification: A view from the nervous system. Cell 96(2):211-224.

Eisen, M.B., P.T. Spellman, P.O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95(25):14863-14868.

Eisenhardt, E.U., and M.H. Bickel. 1994. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. II. Etretinate. Drug Metab. Dispos. 22(1):31-35.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Ellsworth, D.L., D.M. Hallman, and E. Boerwinkle. 1997. Impact of the human genome project on epidemiologic research. Epidemiol. Rev. 19(1):3-13.

Elmazar, M.M., U. Reichert, B. Shroot, and H. Nau. 1996. Pattern of retinoid-induced teratogenic effects: Possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma. Teratology 53(3):158-167.

Elmazar, M.M., R. Ruhl, U. Reichert, B. Shroot, and H. Nau. 1997. RARalpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: Dissection of retinoid receptor-induced pathways. Toxicol. Appl. Pharmacol. 146(1):21-28.

Emmert-Buck, M.R., R.F. Bonner, P.D. Smith, R.F. Chuaqui, Z. Zhuang, S.R. Goldstein, R.A. Weiss, and L.A. Liotta. 1996. Laser capture microdissection. Science 274(5289):998-1001.

Ensenbach, U., and R. Nagel. 1995. Toxicity of complex chemical mixtures: Acute and long-term effects on different life stages of zebrafish (Brachydanio rerio). Ecotoxicol. Environ. Saf. 30(2):151-157.

Ensenbach, U., and R. Nagel. 1997. Toxicity of binary chemical mixtures: Effects on reproduction of zebrafish. Arch. Environ. Contam. Toxicol. 32(2):204-210.

EPA (U.S. Environmental Protection Agency). 1990. Fungicide and Rodenticide Act (FIFRA): Good Laboratory Practice Standards. Final Rule. Fed. Regist. 54(158):34052-34074.

EPA (U.S. Environmental Protection Agency). 1991. Guidelines for Developmental Toxicity Risk Assessment; Notice. Part V. Fed. Regist. 56(234):63798-63826.

EPA (U.S. Environmental Protection Agency). 1995. Guidance for Risk Characterization. Science Policy Council. ORD. February. [Online]. Available: http://search.epa.gov/ordntrnt/ORD/spc/rcguide.htm

EPA (U.S. Environmental Protection Agency). 1996a. Guidelines for Reproductive Toxicity Risk Assessment. Fed. Regist. 61(212):56274-56322.

EPA (U.S. Environmental Protection Agency). 1996b. Proposed Guidelines for Carcinogen Risk Assessment. EPA/600/P-92/003C. Office of Research and Development. Washington, DC.

EPA (U.S. Environmental Protection Agency). 1997. TSCA Test Guidelines, 40 CFR Part 799. Fed. Regist. 62(158):43820-438649.

EPA (U.S. Environmental Protection Agency). 1998a. Chemical Hazard Data Availability Study: What Do We Really Know About the Safety of High Production Volume Chemicals? Office of Pollution Prevention and Toxics. [Online]. Available: http://www.epa.gov/opptintr/chemtest/hazchem.htm

EPA (U.S. Environmental Protection Agency). 1998b. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), Final Report. Office of Prevention, Pesticides, and Toxic Substances. [Online]. Available: http://www.epa.gov/opptintr/opptendo/finalrpt

EPA (U.S. Environmental Protection Agency). 1998c. Health Effects Test Guidelines, OPPTS 870.3800, Reproduction and Fertility Effects. EPA 712-C-98-208, August 1998. [Online]. Available: http://www.epa.gov/opptsfrs/OPPTS_Harmonized/

EPA (U.S. Environmental Protection Agency). 1998d. Health Effects Test Guidelines, OPPTS 870.3700, Prenatal developmental Toxicity Study. EPA 712-C-98-207, August 1998. [Online]. Available: http://www.epa.gov/opptsfrs/OPPTS_Harmonized/

EPA (U.S. Environmental Protection Agency). 1998e. Health Effects Test Guidelines, OPPTS 870.6300, Developmental Neurotoxicity Study. EPA 712-C-98-239, August 1998. [Online]. Available: http://www.epa.gov/opptsfrs/OPPTS_Harmonized/

EPA (U.S. Environmental Protection Agency). 1998f. EPA Guidelines for Neurotoxicity Risk Assessment FRL-6011-3. NTIS PB98-117831. Effective April 30, 1998. [Online]. Available: http://www.epa.gov/ncea

EPA (U.S. Environmental Protection Agency). 1998g. Endocrine Disruptor Screening Program. Fed. Regist. 63(248) ( December 28).

Everson, R.B. 1987. A review of approaches to the detection of genetic damage in the human fetus. Environ. Health Perspect. 74:109-117.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Everson, R.B., E. Randerath, T.A. Avitts, H.A. Schut, and K. Randerath. 1987. Preliminary investigations of tissue specificity, species specificity, and strategies for identifying chemicals causing DNA adducts in human placenta. Prog. Exp. Tumor Res. 31:86-103.

Everson, R.B., E. Randerath, R.M. Santella, T.A. Avitts, I.B. Weistein, and K. Randerath. 1988. Quantitative associations between DNA damage in human placenta, maternal smoking and birth weight. J. Natl. Cancer Inst. 80(8):567-576.

Eyre-Walker, A., and P.D. Keightley. 1999. High genomic deleterious mutation rates in hominids. Nature 397(6717):344-347.


Fambrough, D., K. McClure, A. Kazlauskas, and E.S. Lander. 1999. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 97(6):727-741.

Fantel, A.G. 1996. Reactive oxygen species in developmental toxicity: Review and hypothesis. [Review]. Teratology 53(3):196-217.

Faustman, E.M. 1988. Short-term tests for teratogens. [Review]. Mutat. Res. 205(1-4):355-384.

Faustman, E.M., T.A. Lewandowski, R.A. Ponce, and S.M. Bartell. 1999. Biologically cased dose-responce models for developmental toxicants: Lessons from methylmercury. Inhalaton Toxicol. 11:559-572.

Faustman, E.M., R.A. Ponce, M.R. Seeley, and S.G. Whittaker. 1997. Experimental approaches to evaluate mechanisms of developmental toxicity. Pp.13-41 in Handbook of Developmental Toxicology, R. Hood, ed. Boca Raton, FL: CRC Press.

Faustman, E.M., S.M. Silbernagel, R.A. Fenske, T.M. Burbacher, and R.A. Ponce. 2000. Mechanisms underlying children’s susceptibility to environmental toxicants. Environ. Health Perspect. 108(Suppl.1):13-21.

Fawcett, L.B., S.J. Buck, D.A. Beckman, and R.L. Brent. 1996. Is there a no-effect dose for corticosteroid-induced cleft palate? The contribution of endogenous corticosterone to the incidence of cleft palate in mice. Pediatr. Res. 39(5):856-861.

FDA (U.S. Food and Drug Administration). 1987. Good Laboratory Practice Regulation for Nonclinical Laboratory Studies, Regulatory Program. 21 CFR 58.

FDA (U.S. Food and Drug Administration). 1994. International Conference on Harmonisation: Guideline on Detection of Toxicity to Reproduction for Medicinal Products; Availability. Fed. Regist. 59(183):48746-48752. September 22, 1994.

Fekete, D.M. 1999. Development of the vertebrate ear: Insights from knockouts and mutants. Trends Neurosci. 22(6):263-269.

Feldman, B., W. Poueymirou, V.E. Papaioannou, T.M. DeChiara, and M. Goldfarb. 1995. Requirement of FGF-4 for postimplantation mouse development. Science 267(5195):246-249.

Feng, D-F., G. Cho, and R.F. Doolittle. 1997. Determining divergence times with a protein clock: Update and reevaluation. Proc. Natl. Acad. Sci. U.S.A. 94:13028-13033.

Fernandez-Salguero, P.M., D.M. Hilbert, S. Rudikoff, J.M. Ward, and F.J. Gonzalez. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140(1):173-179.

Ferretti, P., and C. Tickle. 1997. The limbs. Pp.101-132 in Embryos, Genes and Birth Defects, P. Thorogood, ed. Chichester: John Wiley & Sons.

Fex, G., K. Larsson, A. Andersson, and M. Berggren-Soderlund. 1995. Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate. Possible relation to teratogenicity. Arch. Toxicol. 69(8):572-574.

Finnell, R.H., B. Bielec, and H. Nau. 1997a. Anticonvulsant drugs: Mechanisms and pathogenesis of teratogenicity Pp. 121-159 in Drug Toxicity in Embryonic Development II., Handbook of Experimental Pharmacology, Vol. 124/II, R.J. Kavlock, and G.P. Daston, eds. Heidelberg: Springer.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Finnell, R.H., B.C. Wlodarczyk, J.C. Craig, J.A. Piedrahita, and G.D. Bennett. 1997b. Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Am. J. Med. Genet. 70(3):303-311.

Fire, A., S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811.

Flint, O.P. 1993. In vitro tests for teratogens: Desirable endpoints, test batteries and current status of the micromass teratogen test. [Review]. Reprod. Toxicol. 7(Suppl. 1):103-111.

Flint, O.P., and F.T. Boyle. 1985. An in vitro test for teratogens: Its application in the selection of non-teratogenic triazole antifungals. Concepts Toxicol. 3:29-35.

Floss, T., H.H. Arnold, and T. Braun. 1997. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11(16):2040-2051.

Fong, G.H., J. Rossant, M. Gertsenstein, and M.L. Breitman. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376(6535):66-70.

Fort, D.J., E.L. Stover, J.A. Bantle, J.R. Rayburn, M.A. Hull, R.A. Finch, D.T. Burton, S.D. Turley, D.A. Dawson, G. Linder, D. Buchwalter, M. Kumsher-King, and A.M. Gaudet-Hull. 1998. Phase III interlaboratory study of FETAX, Part 2: Interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay-Xenopus( FETAX). Drug Chem. Toxicol. 21(1):1-14.

Francis, N.J., and S.C. Landis. 1999. Cellular and molecular determinants of sympathetic neuron development. Annu. Rev. Neurosci. 22:541-566.

Francis, E.Z., C.A. Kimmel, and D.C. Rees. 1990. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: Summary and implications. Neurotoxicol. Teratol. 12(3):285-292.

Francis-West, P., R. Ladher, A. Barlow, and A. Graveson. 1998. Signalling interactions during facial development. Mech. Dev. 75(1-2):3-28.

Freese, E. 1982. Use of cultured cells in the identification of potential teratogens. Teratog. Carcinog. Mutagen. 2(3-4):355-360.

Fretts, R.C., J. Schmittdiel, F.H. McLean, R.H. Usher, and M.B. Goldman. 1995. Increased maternal age and the risk of fetal death. N. Engl. J. Med. 333(15):953-957.

Friedman, J.M., and J. E. Polifka. 1994. Teratogenic Effects of Drugs: A Resource for Clinicians: TERIS . Baltimore: Johns Hopkins University Press. 703pp.


Galitski, T., A.J. Saldanha, C.A. Styles, E.S. Lander, and G.R. Fink. 1999. Ploidy regulation of gene expression. Science 285(5425):251-254.

Gallo, M.A. 1996. History and scope of toxicology. Pp. 3-11 in Casarett and Doull’s Toxicology, The Basic Science of Poisons, 5th Ed., C.D. Klaassen, M.O. Amdur, and J. Doull, eds. New York: McGraw-Hill.

Geisler, R., G.J. Rauch, H. Baier, F. van Bebber, L. Brobeta, M.P. Dekens, K. Finger, C. Fricke, M.A. Gates, H. Geiger, S. Geiger-Rudolph, D. Gilmour, S. Glaser, L. Gnugge, H. Habeck, K. Hingst, S. Holley, J. Keenan, A. Kirn, H. Knaut, D. Lashkari, F. Maderspacher, U. Martyn, S. Neuhauss, P. Haffter, et al. 1999. A radiation hybrid map of the zebrafish genome. Nat. Genet. 23(1):86-89.

Genbacev, O., T.E. White, C.E. Gavin, and R.K. Miller. 1993. Human trophoblast cultures: Models for implantation and peri-implantation toxicology. Reprod. Toxicol. 7(Suppl. 1):75-94.

Generoso, W.M., J.C. Rutledge, K.T. Cain, L.A. Hughes, and P.W. Braden. 1987. Exposure of female mice to ethylene oxide within hours after mating leads to fetal malformation and death. Mutat. Res. 176(2):269-274.

Gershon, M.D. 1999a. Endothelin and the development of the enteric nervous system. Clin. Exp. Pharmacol. Physiol. 26(12):985-988.

Gershon, M.D. 1999b. Lessons from genetically engineered animal models. II. Disorders of enteric neuronal development: Insights from transgenic mice. Am. J. Physiol. 277(2 Pt. 1):G262-267.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Ghyselinck, N.B., V. Dupe, A. Dierich, N. Messaddeq, J.M. Garnier, C. Rochette-Egly, P. Chambon, and M. Mark. 1997. Role of the retinoic acid receptor beta (RARbeta) during mouse development. Int. J. Dev. Biol. 41(3):425-447.

Goffeau, A., B.G. Barrell, H. Bussey, R.W. Davis, B. Dujon, H. Feldmann, F. Galibert, J.D. Hoheisel, C. Jacq, M. Johnston, E.J. Louis, H.W. Mewes, Y. Murakami, P. Philippsen, H. Tettelin, and S.G. Oliver. 1996. Life with 6000 genes. Science 274:546-567.

Goldberg, J.M., and T. Falcone. 1999. Effect of diethylstilbestrol on reproductive function. Fertil. Steril. 72(1):1-7.

Goldman, L.R., B.J. Apelberg, S. Koduru, C.E. Ward, and R. Sorian. 1999. Healthy from the Start: Why America Needs a Better System to Track and Understand Birth Defects and the Environment. Pew Environmental Health Commission. [Online]. Available: http://pewenvirohealth.jhsph.edu/html/home/home.html.

Golic, K.G., and S. Lindquist. 1989. The FLP recombinase of yeast catalyzes site-specific recombination in the Drosophila genome. Cell 59:499-509.

Goodrich, L.V., L. Milenkovic, K.M. Higgins, and M.P. Scott. 1997. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277(5329):1109-1113.

Graillet, C., G. Pagano, and J.P. Girard. 1993. Stage-specific effects of teratogens on sea-urchin embryogenesis. Teratog. Carcinog. Mutagen. 13(1):1-14.

Granato, M., F.J. van Eeden, U. Schach, T. Trowe, M. Brand, M. Furutani-Seiki, P. Haffter, M. Hammerschmidt, C.P. Heisenberg, Y.J. Jiang, D.A. Kane, R.N. Kelsh, M.C. Mullins, J. Odenthal, and C. Nüsslein-Volhard. 1996. Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development 123:399-413.

Gregg, N.M. 1941. Congenital cataract following German measles in the mother. Trans. Ophthalmol. Soc. Aust. 3:35-45.

Gretchen, J.D. 1999. Molecular mechanisms of liver development and differentiation. Curr. Opin. Cell Biol. 11(6):678-682.

Gruda, M.C., J. van Amsterdam, C.A. Rizzo, S.K. Durham, S. Lira, and R. Bravo. 1996. Expression of FosB during mouse development: Normal development of FosB knockout mice. Oncogene 12(10):2177-2185.

Gurdon, J.B. 1960. Factors responsible for the abnormal development of embryos obtained by nuclear transplantation in Xenopus laevis. J. Embryol. Exp. Morphol. 8:327-341.

Guo, L., L. Degenstein, and E. Fuchs. 1996. Keratinocyte growth factor is required for hair development but not for wound healing. Genes. Dev. 10(2):165-175.

Gurtoo, H.L., C.J. Williams, K. Gottlieb, A.I. Mulhern, L. Caballes, J.B. Vaught, A.J. Marinello, and S.K. Bansal. 1983. Population distribution of placental benzo(a)pyrene metabolism in smokers. Int. J. Cancer 31:29-37.


Haffter, P., and C. Nüsslein-Volhard. 1996. Large scale genetics in a small vertebrate, the zebrafish. Int. J. Dev. Biol. 40(1):221-227.

Haffter, P., M. Granato, M. Brand, M.C. Mullins, M. Hammerschmidt, D.A. Kane, J. Odenthal, F.J. van Eeden, Y.J. Jiang, C.P. Heisenberg, R.N. Kelsh, M. Furutani-Seiki, E. Vogelsang, D. Beuchle, U. Schach, C. Fabian, and C. Nüsslein-Volhard. 1996. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123:1-36.

Hahn, H., L. Wojnowski, A.M. Zimmer, J. Hall, G. Miller, and A. Zimmer. 1998. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat. Med. 4(5):619-622.

Hale, F. 1933. Pigs born without eye balls. J. Hered. 24(3):105-106.

Hall, J.C. 1998. Molecular neurogenetics of biological rhythms. J. Neurogenet. 12(3):115-181.

Hanselaar, A., M. van Loosbroek, O. Schuurbiers, T. Helmerhorst, J. Bulten, and J. Bernhelm. 1997. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer 79(11):2229-2236.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Hanson, J.W., N.C. Myrianthopoulos, M.A. Harvey, and D.W. Smith. 1976. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J. Pediatr. 89(4):662-668.

Harada, Y., and K. Noda. 1988. How the discovery of methyl mercury poisoning in Minamata district came about. Teratology 38(5):544.

Harborne, J.B., and H. Baxter. 1996. Dictionary of Plant Toxins. New York: Wiley. 540pp.

Harland, R., and J. Gerhart. 1997. Formation and function of Spemann’s organizer. Ann. Rev. Cell Dev. Biol. 13:611-667.

Harmon, M.A., M.F. Boehm, R.A. Heyman, and D.J. Mangelsdorf. 1995. Activation of mammalian retinoid X receptors by the insect growth regulator methoprene. Proc. Natl. Acad. Sci. U.S.A. 92(13):6157-6160.

Hartl, D.L., and C.H. Taubes. 1998. Towards a theory of evolutionary adaptation. Genetica 102-103(1-6):525-533.

Hassett, C., L. Aicher, J.S. Sidhu, and C.J. Omiecinski. 1994. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3(3):421-428.

Hatasaka, H.H. 1994. Recurrent miscarriage: Epidemiologic factors, definitions, and incidence. Clin. Obstet. Gynecol. 37(3):625-634.

Hauck, R.S., and H. Nau. 1992. The enantiomers of the valproic acid analogue 2-n-propyl-4-pentynoic acid (4-yn-VPA): Asymmetric synthesis and highly stereoselective teratogenicity in mice. Pharm. Res. 9(7):850-855.

Heberlein, U., C.M. Singh, A.Y. Luk, and T.J. Donohoe. 1995. Growth and differentiation in the Drosophila eye coordinated by hedgehog. Nature 373(6516):709-711.

Hebert, J.M., T. Rosenquist, J. Gotz, and G.R. Martin. 1994. FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell 78(6):1017-1025.

Hemminki, K., and P. Vineis. 1985. Extrapolation of the evidence on teratogenicity of chemicals between humans and experimental animals: Chemicals other than drugs. Teratog. Carcinog. Mutagen. 5(4):251-318.

Henkemeyer, M., D.J. Rossi, D.P. Holmyard, M.C. Puri, G. Mbamalu, K. Harpal, T.S. Shih, T. Jacks, and T. Pawson. 1995. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377(6551):695-701.

Henry, E.C., and R.K. Miller. 1986. Comparison of the disposition of diethylstilbestrol and estradiol in the fetal rat. Correlation with teratogenic potency. Biochem. Pharmacol. 35(12):1993-2001.

Henry, E.C., R.K. Miller, and R.B. Baggs. 1984. Direct fetal injections of diethylstilbestrol and 17 beta-estradiol: A method for investigating their teratogenicity. Teratology 29(2):297-304.

Henry, T.R., J.M. Spitsbergen, M.W. Hornung, C.C. Abnet, and R.E. Peterson. 1997. Early life stage toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. 142(1):56-68.

Herbst, A.L. 1981. Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer 48(2 Suppl.):484-488.

Herbst, A.L., H. Ulfelder, and D.C. Poskanzer. 1971. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284(15):878-881.

Herrmann, K. 1993. Effects of the anticonvulsant drug valproic acid and related substances on the early development of the zebrafish (Brachydanio-rerio). Toxicol. in Vitro 7(1):41-54.

Hilberg, F., A. Aguzzi, N. Howells, and E.F. Wagner. 1993. c-jun is essential for normal mouse development and hepatogenesis. Nature 365(6442):179-181.

Hirayama, K. 1980. Effect of amino acids on brain uptake of methyl mercury. Toxicol. Appl. Pharmacol. 55(2):318-323.

Hirayama, K. 1985. Effects of combined administration of thiol compounds and methylmercury chloride on mercury distribution in rats. Biochem. Pharmacol. 34(11):2030-2032.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Hishida, R., and H. Nau. 1998. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione . Teratog. Carcinog. Mutagen. 18(2):49-61.

Hiss, W., Sr. 1880-1885. Anatomie Menschlicher Embryonen. Leipzig: F.C.W. Vogel.

Hogan, B.L., C. Thaller, and G. Eichele. 1992. Evidence that Hensen’s node is a site of retinoic acid synthesis. Nature 359(6392):237-241.

Holland, P.W., J. Garcia-Fernandez, N.A. Williams, and A. Sidow. 1994. Gene duplications and the origins of vertebrate development. Dev. (Suppl.):125-33.

Holme, R.H., and K.P. Steel. 1999. Genes involved in deafness. Curr. Opin. Genet. Dev. 9(3):309-314.

Holmes, L.B. 1997. Impact of the detection and prevention of developmental abnormalities in human studies. Reprod. Toxicol. 11(2/3):267-269.

Holtfreter, J. 1947. Neural induction in explants which have passed through a sublethal cytolysis. J. Exp. Zool. 106:197-222.

Honda, K., T. Hatayama, K. Takahashi, and M. Yukioka. 1991. Heat-shock proteins in human and mouse embryonic cells after exposure to heat shock or teratogenic agents. Teratog. Carcinog. Mutagen. 11(5):235-244.

Honeycutt, D., L. Dunlap, H. Chen, and G. al Homsi. 1999. The Cost of Developmental Disabilities. Final Report. Task Order No. 021-09. RTI Project No. 6900-009. Center for Economics Research, Research Triangle Institute, NC.

Hooghe, R.J., and D. Ooms. 1995. Use of the fluorescence-activated cell sorter (FACS) for in vitro assays of developmental toxicity. Toxicol. in Vitro 9(3):349-354.

Horster, M.F., G.S. Braun, and S.M. Huber. 1999. Embryonic renal epithelia: Induction, nephrogenesis, and cell differentiation. Physiol. Rev. 79(4):1157-1191.

Hrabe de Angelis, M., J. McIntyre, II, and A. Gossler. 1997. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 386(6626):717-721.

Hwang, S.J., T.H. Beaty, I. McIntosh, T. Hefferon, and S.R. Pany. 1998. Association between homeobox-containing gene MSX1 and the occurrence of limb deficiency. Am. J. Med. Genet. 75:419-423.

Hwang, S.J., T.H. Beaty, S.R. Panny, N.A. Street, J.M. Joseph, S. Gordon, I. McIntosh, and C.A. Francomano. 1995. Association study of transforming growth factor alpha (TGF alpha) Taq1 polymorphism and oral clefts: Indication of a gene-environment interaction in a population-based sample of infants with birth defects. Am. J. Epidemiol. 141(7):629-636.


ICBD (International Clearinghouse for Birth Defects Monitoring Systems). 1991. Congenital Malformations Worldwide. Amsterdam: Elsevier. 220pp.

Imura, N., K. Miura, M. Inokawa, and S. Nakada. 1980. Mechanism of methylmercury cytotoxicity: By biochemical and morphological experiments using cultured cells. Toxicology 17(2):241-254.

Incardona, J.P., W. Gaffield, R.P. Kapur, and H. Roelink. 1998. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125(18):3553-3562.

Ingham, P.W. 1989. Drosophila development. Curr. Opin. Cell Biol. 1(6):1127-1131.

Ingram, J.L., and P.M. Rodier. 1998. Valproic acid alters expression of HOX A1 in rat embryos: A mechanism of teratogenesis? Teratology 57(4-5):191.

Iulianella, A., and D. Lohnes. 1997. Contribution of retinoic acid receptor gamma to retinoid-induced craniofacial and axial defects. Dev. Dyn. 209(1):92-104.

Iyer, N.V., S.W. Leung, and G.L. Semenza. 1998. The human hypoxia-inducible factor 1alpha gene: HIF1A structure and evolutionary conservation. Genomics 52(2):159-165.

Iyer, V.R., M.B. Eisen, D.T. Ross, G. Schuler, T. Moore, J.C.F. Lee, J.M. Trent, L.M. Staudt, J. Hudson, Jr., M.S. Boguski, D. Lashkari, D. Shalon, D. Botstein, and P.O. Brown. 1999. The transcriptional program in the response of human fibroblasts to serum. Science 283(5398):83-87.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Jacobs, P.A., and T.J. Hassold. 1995. The origin of numerical chromosome abnormalities. Adv. Genet. 33:101-133.

Jaffe, R. 1998. First trimester utero-placental circulation: Maternal-fetal interaction. J. Perinat. Med. 26(3):168-174.

Ji, Q.S., G.E. Winnier, K.D. Niswender, D. Horstman, R. Wisdom, M.A. Magnuson, and G. Carpenter. 1997. Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc. Natl. Acad. Sci. U.S.A. 94(7):2999-3003.

Johnson, E.M., L.M. Newman, B.E.G. Gabel, T.F. Boerner, and L.A. Dansky. 1988. An analysis of the Hydra assay’s applicability and reliability as a developmental toxicity prescreen. J. Am. Coll. Toxicol. 7(2):111-126.

Johnson, L., D. Greenbaum, K. Cichowski, K. Mercer, E. Murphy, E. Schmitt, R.T. Bronson, H. Umanoff, W. Edelmann, R. Kucherlapati, and T. Jacks. 1997. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11(19):2468-2481.

Johnson, R.L., and C.J. Tabin. 1997. Molecular models for vertebrate limb development. Cell 90(6):979-990.

Johnson, R.S., B.M. Spiegelman, and V. Papaioannou. 1992. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71(4):577-586.

Johnson, R.S., B. van Lingen, V.E. Papaioannou, and B.M. Spiegelman. 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7(7B):1309-1317.

Johnson, V.P., V.W. Swayze II, Y. Sato, and N.C. Andreasen. 1996. Fetal alcohol syndrome: Craniofacial and central nervous system manifestations. Am. J. Med. Genet. 61(4):329-339.

Jones, K.L., and D.W. Smith. 1973. Recognition of the fetal alcohol syndrome in early infancy. Lancet 2(7836):999-1001.

Jones, K.L., D.W. Smith, C.N. Ulleland, and A.P. Streissguth. 1973. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1(7815):1267-1271.

Joshi, R.L., B. Lamothe, N. Cordonnier, K. Mesbah, E. Monthioux, J. Jami, and D. Bucchini. 1996. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15(7):1542-1547.

Juchau, M.R. 1980. Drug biotransformation in the placenta. Pharmacol. Ther. 8(3):501-524.

Juchau, M.R., S.T. Chao, and C.J. Omiecinski. 1980. Drug metabolism by the human fetus. Clin. Pharmacokinet. 5(4):320-339.


Kao, J., N.A. Brown, B. Schmid, E.H. Goulding, and S. Fabro. 1981. Teratogenicity of valproic acid: In vivo and in vitro investigations. Teratog. Carcinog. Mutagen. 1:367-382.

Kassim, N.M., S.W. McDonald, O. Reid, N.K. Bennett, D.P. Gilmore, and A.P. Payne. 1997. The effects of pre- and postnatal exposure to the nonsteroidal antiandrogen flutamide on testis descent and morphology in the albino Swiss rat. J. Anat. 190(Pt. 4):577-588.

Kastner, P., J.M. Grondona, M. Mark, A. Gansmuller, M. LeMeur, D. Decimo, J.L. Vonesch, P. Dolle, and P. Chambon. 1994. Genetic analysis of RXR alpha developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78(6):987-1003.

Kastner, P., M. Mark, N. Ghyselinck, W. Krezel, V. Dupe, J.M. Grondona, and P. Chambon. 1997a. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124(2):313-326.

Kastner, P., N. Messaddeq, M. Mark, O. Wendling, J.M. Grondona, S. Ward, N. Ghyselinck, and P. Chambon. 1997b. Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early differentiation of embryonic ventricular cardiomyocytes. Development 124(23):4749-4758.

Kaufman, R.H., E. Adam, G.L. Binder, and E. Gerthoffer. 1980. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am. J. Obstet. Gynecol. 137(3):299-308.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Kauffmann, R.C., Y. Qian, A. Vogt, S.M. Sebti, A.D. Hamilton, and R.W. Carthew. 1995. Activated Drosophila Ras1 is selectively suppressed by isoprenyl transferase inhibitors. Proc. Natl. Acad. Sc.i. U.S.A. 92(24):10919-10923.

Kavlock, R.J., B.C. Allen, E.M. Faustman, and C.A. Kimmel. 1995. Dose-response assessments for developmental toxicity. IV. Benchmark doses for fetal weight changes. Fundam. Appl. Toxicol. 26(2):211-222.

Keeler, R.F., and W. Binns. 1968. Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources. Teratology 1(1):5-10.

Keeler, R.F., and A.T. Tu. 1991. Toxicology of Plant and Fungal Compounds. Handbook of Natural Toxins, Vol. 6. New York: M. Dekker. 644pp.

Keller, S.J., and M.K. Smith. 1982. Animal virus screens for potential teratogens. I. Poxvirus morphogenesis. Teratog. Carcinog. Mutagen. 2(3-4):361-374.

Kelley, R.I., E. Roessler, R.C.M. Hennekam, G.L. Feldman, K. Kosaki, M.C. Jones, J.C. Palumbos, and M. Muenke. 1996. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: Does abnormal cholesterol metabolism affect the function of Sonic hedgehog? Am. J. Med. Genet. 66:478-484.

Kelsh, R.N., M. Brand, Y.J. Jiang, C.P. Heisenberg, S. Lin, P. Haffter, J. Odenthal, M.C. Mullins, F.J. van Eeden, M. Furutani-Seiki, M. Granato, M. Hammerschmidt, D.A. Kane, R.M. Warga, D. Beuchle, L. Vogelsang, and C. Nüsslein-Volhard. 1996. Zebrafish pigmentation mutations and the processes of neural crest development. Development 123:369-389.

Kennerdell, J.R., and R.W. Carthew. 1998. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95(7):1017-1026.

Kerper, L.E., N. Ballatori, and T.W. Clarkson. 1992. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am. J. Physiol. 262(5):R761-R765.

Kerper, L.E., E.M. Mokrzan, T.W. Clarkson, and N. Ballatori. 1996. Methylmercury efflux from brain capillary endothelial cells is modulated by intracellular glutathione but not ATP. Toxicol. Appl. Pharmacol. 141(2):526-531.

Khan, S.A., R.B. Ball, and W.J. Hendry, III. 1998. Effects of neonatal administration of diethylstilbestrol in male hamsters: Disruption of reproductive function in adults after apparently normal pubertal development. Biol. Reprod. 58(1):137-142.

Khoury, M.J., T.H. Beaty, and B.H. Cohen, eds. 1993a. Scope and strategies of genetic epidemiology. Pp. 3-25 in Fundamentals of Genetic Epidemiology. New York: Oxford University Press.

Khoury, M.J., T.H. Beaty, and B.H. Cohen, eds. 1993b. Applications of genetic epidemiology in medicine and pubic health. Pp. 312-327 in Fundamentals of Genetic Epidemiology. New York: Oxford University Press.

Khoury, M.J., M.G. Farias, and J. Mulinare. 1989. Does maternal cigarette smoking during pregnancy cause cleft lip and palate in the offspring? Am. J. Dis. Child. 143:333-337.

Khoury, M.J., L.M. James, W.D. Flanders, and J.D. Erickson. 1992. Interpretation of recurring weak associations obtained from epidemiologic studies of suspected humans teratogens. Teratology 46:69-77.

Kimmel, C.A. 1997. Introduction to the symposium. Reprod. Toxicol. 11(2-3):261-263.

Kimmel, C.A., J.F. Holson, C.J. Hogue, and G. Carlo. 1984. Reliability of Experimental Studies for Predicting Hazards to Human Development. NCTR Technical Report for Experiment No. 6015. National Center for Toxicological Research, Jefferson, AR.

Kimmel, C.A., et al. 1997. New Approaches for Assessing the Etiology and Risks of Developmental Abnormalities From Chemical Exposure. Symposium Proceedings. National Academy of Sciences Auditorium, December 11-12, 1995, Washington, DC.

Kimmel, G.L., K. Smith, D.M. Kochhar, and R.M. Pratt. 1982. Overview of in vitro teratogenicity testing: Aspects of validation and application to screening. Teratog. Carcinog. Mutagen. 2(3-4):221-229.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Kisaalita, W.S. 1997. Susceptibility of differentiating neuroblastoma cells to developmental toxicants’ cytotoxic effects is culture age-dependent. In Vitro Toxicol. 10(3):359-363.

Kistler, A., and W.B. Howard. 1990. Testing of retinoids for teratogenicity in vitro: Use of micromass limb bud cell culture. Methods Enzymol. 190:427-433.

Klambt, C., L. Glazer, and B.-Z Shilo. 1992. Breathless, a Drosophila FGF receptor homolog, is essential for migration of tracheal and specific midline glial cells. Genes Dev. 6:1668-1678.

Knudsen, T.B. 1997. Cell death. Pp. 209-244 in Drug Toxicity in Embryonic Development, Vol. 1., R.J. Kavlock, and G.P. Daston, eds. Heidelberg: Springer.

Kochhar, D.M. 1982. Embryonic limb bud organ culture in assessment of teratogenicity of environmental agents. Teratog. Carcinog. Mutagen. 2(3-4):303-312.

Kochhar, D.M., H. Jiang, J.D. Penner, R.L. Beard, and A.S. Chandraratna. 1996. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid. Chem. Biol. Interact. 100(1):1-12.

Kochhar, D.M., H. Jiang, J.D. Penner, A.T. Johnson, and R.A. Chandraratna. 1998. The use of a retinoid receptor antagonist in a new model to study vitamin A-dependent developmental events. Int. J. Dev. Biol. 42(4):601-608.

Koera, K., K. Nakamura, K. Nakao, J. Miyoshi, K. Toyoshima, T. Hatta, H. Otani, A. Aiba, and M. Katsuki. 1997. K-ras is essential for the development of the mouse embryo. Oncogene 15(10):1151-1159.

Konopka, R.J., and S. Benzer. 1971. Clock mutants of Drosophila melanogaster. Proc. Natl. Acad. Sci. U.S.A. 68(9):2112-2116.

Kost, T.A., and J.P. Condreay. 1999. Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr. Opin. Biotechnol. 10(5):428-433.

Kraft, J.C., and M.R. Juchau. 1993. Conceptional biotransformation of microinjected retinoids. Correlations with dysmorphogenic activities. Ann. N.Y. Acad. Sci. 678:338-340.

Kraft, J.C., T. Shepard, and M.R. Juchau. 1993. Tissue levels of retinoids in human embryos/fetuses. Reprod. Toxicol. 7(1):11-15.

Kraus, P., and T. Lufkin. 1999. Mammalian Dlx homeobox gene control of craniofacial and inner ear morphogenesis. J. Cell Biochem. Suppl. 32-33:133-140.

Kroll, K.L., and E. Amaya. 1996. Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation. Development 122(10):3173-3183.

Krumlauf, R. 1994. Hox genes in vertebrate development. Cell 78(2):191-201.


LaBonne, C., and M. Bronner-Fraser. 1999. Molecular mechanisms of neural crest formation. Annu. Rev. Cell Dev. Biol. 15:81-112.

Lammer, E.J., D.T. Chen, R.M. Hoar, N.D. Agnish, P.J. Benke, J.T. Braun, C.J. Curry, P.M. Fernhoff, A.W. Grix, Jr., I.T. Lott, J.M. Richard, and S.C. Sun. 1985. Retinoic acid embryopathy. N. Engl. J. Med. 313(14):837-841.

Lampen, A., S. Siehler, U. Ellerbeck, M. Gottlicher, and H. Nau. 1999. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: Activation of the peroxisomal proliferator-activated receptor (PPARdelta) . Toxicol. Appl. Pharmacol. 160(3):238-249.

Lampron, C., C. Rochette-Egly, P. Gorry, P. Dolle, M. Mark, T. Lufkin, M. LeMeur, and P. Chambon. 1995. Mice deficient in cellular retinoic acid binding protein II (CRABPII) or in both CRABPI and CRABPII are essentially normal. Development 121(2):539-548.

Lander, E.S., and N.J. Schork. 1994. Genetic dissection of complex traits. Science 265(5181):2037-2048.

Langenbach, R., P.B. Smith, and C. Crespi. 1992. Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology. Mutat. Res. 277(3):251-275.

Lau, M.M., C.E. Stewart, Z. Liu, H. Bhatt, P. Rotwein, and C.L. Stewart. 1994. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 8(24):2953-2963.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Lave, L.B., and G.S. Omenn. 1986. Cost-effectiveness of short-term tests for carcinogenicity. Nature 324(6092):29-34.

Le Couteur, A., A. Bailey, S. Goode, A. Pickles, S. Robertson, I. Gottesman, and M. Rutter. 1996. A broader phenotype of autism: The clinical spectrum in twins. J. Child. Psychol. Psychiatry 37(7):785-801.

Lee, C.H., and L.N. Wei. 1999. Characterization of an inverted repeat with a zero spacer (IR0)-type retinoic acid response element from the mouse nuclear orphan receptor TR2-11 gene. Biochemistry 38(27):8820-8825.

Lee, K.J., and T.M. Jessell. 1999. The specification of dorsal cell fates in the vertebrate central nervous system. Annu. Rev. Neurosci. 22:261-294.

Lee, K.F., E. Li, L.J. Huber, S.C. Landis, A.H. Sharpe, M.V. Chao, and R. Jaenisch. 1992. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69(5):737-749.

Lemoine, P., H. Harousseau, J.P. Borteyru, and J.C. Menuet. 1968. Les enfants de parents alcooligues: Anomalies observees, a propos de 127 cas. [in French]. Arch. Franc. Pediatr. 25:830-832.

Lenz, W. 1961. Kindliche Missbildungen nach Medikament-Einnahme während der Gravidität? In Fragen aus der Praxis. [in German]. Dtsch Med. Wschr. 86(32):2555-2556.

Lenz, W., and K. Knapp. 1962. Die Thalidomid-embryopathie. [in German]. Dtsch. Med. Wschr. 87:1232-1242.

Leppig, K.A., M.M. Werler, C.I. Cann, C.A. Cook, and L.B. Holmes. 1987. Predictive value of minor anomalies. I. Association with major malformations. J. Pediatr. 110(4):530-537.

Leroux, B.G., W.M. Leisenring, S.H. Moolgavkar, and E.M. Faustman. 1996. A biologically-based dose-response model for developmental toxicology. Risk Anal. 16(4):449-458.

Li, E., H.M. Sucov, K.F. Lee, R.M. Evans, and R. Jaenisch. 1993. Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc. Natl. Acad. Sci. U.S.A. 90(4):1590-1594.

Limbird, L.E., and P. Taylor. 1998. Endocrine disruptors signal the need for receptor models and mechanisms to inform policy. Cell 93(2):157-163.

Lin, Y.J., L. Seroude, and S. Benzer. 1998. Extended life-span and stress resistance in the Drosophila mutant methuselah. Science 282(5390):943-946.

Liu, F., H.Y. Wu, R. Wesselschmidt, T. Kornaga, and D.C. Link. 1996. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 5(5):491-501.

Liu, J.P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75(1):59-72.

Lohnes, D., P. Kastner, A. Dierich, M. Mark, M. LeMeur, and P. Chambon. 1993. Function of retinoic acid receptor gamma in the mouse. Cell 73(4):643-658.

Lohnes, D., M. Mark, C. Mendelsohn, P. Dolle, A. Dierich, P. Gorry, A. Gansmuller, and P. Chambon. 1994. Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 120(10):2723-2748.

Löscher, W. 1999. Valproate: A reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol. 58(1):31-59.

Lufkin, T., D. Lohnes, M. Mark, A. Dierich, P. Gorry, M.P. Gaub, M. LeMeur, and P. Chambon. 1993. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc. Natl. Acad. Sci. U.S.A. 90(15):7225-7229.

Luo, J., P. Pasceri, R.A. Conlon, J. Rossant, and V. Giguere. 1995. Mice lacking all isoforms of retinoic acid receptor beta develop normally and are susceptible to the teratogenic effects of retinoic acid. Mech. Dev. 53(1):61-71.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Lynch, D.W., R.L. Schuler, R.D. Hood, and D.G. Davis. 1991. Evaluation of Drosophila for screening developmental toxicants: Test results with 18 chemicals and presentation of a new Drosophila bioassay. Teratog. Carcinog. Mutagen. 11(3):147-173.

Lydon, J.P., F.J. DeMayo, O.M. Conneely, and B.W. O’Malley. 1996. Reproductive phenotpes of the progesterone receptor null mutant mouse. J. Steroid Biochem. Mol. Biol. 56(1-6 Spec. No.):67-77.

Lydon, J.P., F.J. DeMayo, C.R. Funk, S.K. Mani, A.R. Hughes, C.A. Montgomery, Jr., G. Shyamala, O.M. Conneely, and B.W. O’Malley. 1995. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9(18):2266-2278.


Makrides, S.C. 1999. Components of vectors for gene transfer and expression in mammalian cells. Protein Expr. Purif. 17(2):183-202.

Makris, S., K. Raffaele, W. Sette, and J. Seed. 1998. A Retrospective Analysis of Twelve Developmental Neurotoxicity Studies. Draft. Submitted to the U.S. EPA Office of Prevention, Pesticides and Toxic Substances (OPPTS). Dated 11/12/98. [Online]. Available: http://www.epa.gov/scipoly/sap/1998/index.htm

Malakoff, D. 2000. The rise of the mouse, biomedicine’s model mammal. Science 288(5464):248-253.

Manchester, D.K., N.B. Parker, and C.M. Bowman. 1984. Maternal smoking increases xenobiotic metabolism in placenta but not umbilical vein endothelium. Pediatr. Res. 18(11):1071-1075.

Mansour, S.L. 1994. Targeted disruption of int-2 (fgf-3) causes developmental defects in the tail and inner ear. Mol. Reprod. Dev. 39(1):62-67.

Mangelsdorf, D.J., and R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83(6):841-850.

March of Dimes. 1999. Facts and Figures of Birth Defects. [Online]. Available: http://www.modimes.org/HealthLibrary2/FactsFigures/stats.htm#BirthDefects

Marden P.M., D.W. Smith, and M.J. McDonald. 1964. Congenital anomalies in the newborn infant, including minor variations. J. Pediatr. 64(3):357-371.

Marshall, H., A. Morrison, M. Studer, H. Popperl, and R. Krumlauf. 1996. Retinoids and Hox genes. FASEB J. 10(9):969-978.

Marshall, H., S. Nonchev, M.H. Sham, I. Muchamore, A. Lumsden, and R. Krumlauf. 1992. Retinoic acid alters hindbrain Hox code and induces transformation of rhombomeres 2/3 into a 4/5 identity. Nature 360(6406):737-741.

Martin, G.R. 1998. The roles of FGFs in the early development of vertebrate limbs. Genes Dev. 12(11):1571-1586.

Martz, F., C. Failinger, III, and D.A. Blake. 1977. Phenytoin teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue. J. Pharmacol. Exp. Ther. 203(1):231-239.

Mastroianni, A.C., R. Faden, and D. Federman, eds. 1994. Risks to reproduction and offspring. Pp. 175-202 in Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. Washington, DC: National Academy Press.

Mattison, D.R. 1997. Introduction. Session IV: Implications of new approaches for improved risk assessment for developmental abnormalities. Reprod. Toxicol. 11(2/3):437-441.

McAvoy, J.W., C.G. Chamberlain, R.U. de Iongh, A.M. Hales, and F.J. Lovicu. 1999. Lens development. Eye 13(Pt. 3b):425-437.

McBride, W.G. 1961. Thalidomide and congenital abnormalities. [Letter]. Lancet 2:1358.

McCartney-Francis, N.L., D.E. Mizel, M. Frazier-Jessen, A.B. Kulkarni, J.B. McCarthy, and S.M. Wahl. 1997. Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice. Am. J. Pathol. 151(5):1281-1288.

McClung, C., and J. Hirsh. 1999. The trace amine tyramine is essential for sensitization to cocaine in Drosophila. Curr. Biol. 9(16):853-860.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

McGinnis, W., M.S. Levine, E. Hafen, A. Kuroiwa, and W.J. Gehring. 1984a. A conserved DNA sequence in homoeotic genes of the Drosophila Antennapedia and bithorax complexes. Nature 308:428-433.

McGinnis, W., R.L. Garber, J. Wirz, A. Kuroiwa, and W.J. Gehring. 1984b. A homologous protein-coding sequence in Drosophila homeotic genes and its conservation in other metazoans. Cell 37(2):403-408.

McLachlan, J.A., R.R. Newbold, and B.C. Bullock. 1980. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstil-bestrol. Cancer Res. 40(11):3988-3999.

McMahon, A.P., A.L. Joyner, A. Bradley, and J.A. McMahon. 1992. The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1-mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell 69(4):581-595.

Mello, C.C., J.M. Kramer, D. Stinchcomb, and V. Ambros. 1991. Efficient gene transfer in C. elegans: Extrachromosomal maintenance and integration of transforming sequences. EMBO J. 10(12):3959-3970.

Mendel, G. 1865. Versuche uber Pflanzen-Hybriden. Verh. Naturforshung Ver. Brunn. 4:3-47. Translated by W.A. Bateson as “ Experiments in Plant Hybridization”, and reprinted in J.A. Peters, 1959, Classic Papers in Genetics. Englewood Cliffs, NJ: Prentice-Hall.

Mendelsohn, C., D. Lohnes, D. Decimo, T. Lufkin, M. LeMeur, P. Chambon, and M. Mark. 1994. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120(10):2749-2771.

Meraz, M.A., J.M. White, K.C. Sheehan, E.A. Bach, S.J. Rodig, A.S. Dighe, D.H. Kaplan, J.K. Riley, A.C. Greenlund, D. Campbell, K. Carver-Moore, R.N. DuBois, R. Clark, M. Aguet, and R.D. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84(3):431-442.

Mercola, M. 1999. Embryological basis for cardiac left-right asymmetry. Semin. Cell Dev. Biol. 10(1):109-116.

Metzstein, M.M., G.M. Stanfield, and H.R. Horvitz. 1998. Genetics of programmed cell death in C. elegans: Past, present and future. Trends Genet. 14(10):410-416.

Meyers, E.N., M. Lewandoski, and G.R. Martin. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18(2):136-141.

Miettinen, P.J., D. Warburton, D. Bu, J.S. Zhao, J.E. Berger, P. Minoo, T. Koivisto, L. Allen, L. Dobbs , Z. Werb, and R. Derynck. 1997. Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev. Biol. 186(2):224-236.

Mikic, B., M.C. Van der Meulen, D.M. Kingsley, and D.R. Carter. 1996. Mechanical and geometric changes in the growing femora of BMP-5 deficient mice. Bone 18(6):601-607.

Miller, C., and D.A. Sassoon. 1998. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125(16):3201-3211.

Miller, C., K. Degenhardt, and D.A. Sassoon. 1998. Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis. Nat. Genet. 20(3):228-230.

Miller, M.S., M.R. Juchau, F.P. Guengerich, D.W. Nebert, and J.L. Raucy. 1996. Drug metabolic enzymes in developmental toxicology. Fundam. Appl. Toxicol. 34(2):165-175.

Miller, R.K. 1991. Fetal drug therapy: Principles and issues. Clin. Obs. Gyn. 34(2):241-250.

Miller, R.K., M.E. Heckmann, and R.C. McKenzie. 1982. Diethylstilbestrol: Placental transfer, metabolism, covalent binding and fetal distribution in the Wistar rat. J. Pharmacol. Exp. Ther. 220(2):358-365.

Miller, R.K., A.G. Hendrickx, J.L. Mills, H. Hummler, and U.W. Wiegand. 1998. Periconceptional vitamin A use: How much is teratogenic? Reprod. Toxicol. 12(1):75-88.

Milunsky, A., J.W. Graef, and M.F. Gaynor, Jr. 1968. Methotrexate-induced congenital malformations. J. Pediatr. 72(6):790-795.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Mimura, J., K. Yamashita, K. Nakamura, M. Morita, T.N. Takagi, K. Nakao, M. Ema, K. Sogawa, M. Yasuda, M. Katsuki, and Y. Fujii-Kuriyama. 1997. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2(10):645-654.

Mirkes, P.E. 1996. Prospects for the development of validated screening tests that measure developmental toxicity potential: View of one skeptic. Teratology 53(6):334-338.

Mirkes, P.E., and S.A. Little. 1998. Teratogen-induced cell death in postimplantation mouse embryos: Differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ. 5(7):592-600.

Missero, C., G. Cobellis, M. De Felice, and R. Di Lauro. 1998. Molecular events involved in differentiation of thyroid follicular cells. Mol. Cell Endocrinol. 140(1-2):37-43.

Mizell, M., and E.S. Romig. 1997. The aquatic vertebrate embryo as a sentinel for toxins: Zebrafish embryo dechorionation and perivitelline space microinjection. Int. J. Dev. Biol. 41(2):411-423.

Moerman, D.G., and A. Fire. 1997. Muscle: Structure, function and development. Pp. 417-470 in C. Elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press.

Mokrzan, E.M., L.E. Kerper, N. Ballatori, and T.W. Clarkson. 1995. Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L. J. Pharmacol. Exp. Ther. 272 (3):1277-1284.

Montgomery, J.M., J.S. Fleming, and R.G. Mills. 1999. Evidence for a neural inhibitory factor which downregulates fetal-type acetylcholine receptor expression in skeletal muscle cell lines. Brain Res. 818(2):346-354.

Monod, J., and F. Jacob. 1961. General conclusions: Telonomic mechanisms in cellular metabolism, growth, and differentiation. Cold Spring Harbor Sympos. Quant. Biol. 26:389-401.

Moore, J.A., G.P. Daston, E. Faustman, M.S. Golub, W.L. Hart, C. Hughes, Jr., C.A. Kimmel, J.C. Lamb, IV, B.A. Schwetz, and A.R. Scialli. 1995. An evaluative process for assessing human reproductive and developmental toxicity of agents. Reprod. Toxicol. 9(1):61-95.

Moore, J.A., and an Expert Scientific Committee. 1997. An assessment of boric acid and borax using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents. Reprod. Toxicol. 11(1):123-160.

Moore, M.W., R.D. Klein, I. Farinas, H. Sauer, M. Armanini, H. Phillips, L.F. Reichardt, A.M. Ryan, K. Carver-Moore, and A. Rosenthal. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382(6586):76-79.

Morales-Alcelay, S., S.G. Copin, J.A. Martinez, P. Morales, S. Minguet, M.L. Gaspar, and M.A. Marcos. 1998. Developmental hematopoiesis. Crit. Rev. Immunol. 8(6):485-501.

Morgan, T.H. 1934. Pp. 9-10 in Embryology and Genetics. New York: Columbia University Press.

Musselman, A.C., G.D. Bennett, K.A. Greer, J.H. Eberwine, and R.H. Finnell. 1994. Preliminary evidence of phenytoin-induced alterations in embryonic gene expression in a mouse model. Reprod. Toxicol. 8(5):383-395.

Myers, R.M., N. Risch, D. Spyker, and L. Lotspeich. 1998. A Full Genome Screen for Susceptibility Genes to Autism by Linkage Analysis in Ninety Multiplex Families. 48th Annual Meeting of the American Society of Human Genetics. Denver, CO, 27-31 Oct. 1998.


Nanson, J.L. 1992. Autism in fetal alcohol syndrome: A report of six cases. Alcohol Clin. Exp. Res. 16(3):558-565.

NAREP (North American Registry of Epilepsy and Pregnancy). 1998. A North American Registry for Epilepsy and Pregnancy, a unique public/private partnership of health surveillance. Epilepsia 39(7):793-798.

Nau, H. 1986. Species differences in pharmacokinetics and drug teratogenesis. Environ. Health Perspect. 70:113-129.

Nau, H. 1994. Valproic acid induced neural tube defects. Pp.144-160 in Neural Tube Defects, G. Bock, and J. Marsh, eds. Chichester, Sussex, UK: John Wiley.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Nau, H., M. Trotz, and C. Wegner. 1985. Controlled-rate drug administration in testing for toxicity, in particular teratogenicity: Toward interspecies bioequivalence. Pp. 143-157 in Topics in Pharmaceutical Sciences 1985, D.D. Breimer, and P. Speiser, eds. New York: Elsevier.

Nau, H., I. Chaoud, L. Dencker, E.J. Lammer, and W.J. Scott. 1994. Teratogenicity of vitamin A and retinoids. Pp. 615-663 in Vitamin A in Health and Diseases, R. Blomhoff, ed. New York: Marcel Dekker.

Nau, H., G. Tzimas, M. Mondry, C. Plum, and H.L. Spohr. 1995. Antiepileptic drugs alter endogenous retinoid concentrations: A possible mechanism of teratogenesis of anticonvulsant therapy. Life Sci. 57(1):53-60.

Nau, H., R. Zierer, H. Spielmann, D. Neubert, and C. Gansau. 1981. A new model for embryotoxicity testing: Teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci. 29(26):2803-2814.

NBDPN (National Birth Defects Prevention Network). 2000. [Online]. Available: http://www.nbdpn.org/NBDPN.

NCHS. (National Center for Health Statistics). 1998. Report of Final Natality Statistics, 1996. In: Latest Birth Statistics for the Nation Released. Vol. 46(11)( suppl.). PHS 98-1120. National Center for Health Statistics. 100pp. [Online]. Available: http://www.cdc.gov/nchswww/releases/98news/98news/natal96.htm.

Nebert, D.W. 1989. The Ah locus: Genetic differences in toxicity, cancer, mutation and birth defects. CRC Crit. Rev. Toxicol. 20(3):153-174.

Nebert, D.W. 1994. Drug-metabolizing enzymes in ligand-modulated transcription. Biochem. Pharmacol. 47(1):25-37.

Nebert, D.W. 1999. Pharmacogenetics and pharmacogenomics: Why is this relevant to the clinical geneticist? Clin. Genet. 56(4):247-258.

Nebert, D.W., and J.J. Duffy. 1997. How knockout mouse lines will be used to study the role of drug-metabolizing enzymes and their receptors during reproduction, development, and environmental toxicity, cancer and oxidative stress. Biochem. Pharmacol. 53(3):249-254.

Nebert, D.W., J. Winker, and H.V. Gelboin. 1969. Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. Cancer Res. 29(10):1763-1769.

Nebert, D.W., A.L. Roe, M.Z. Dieter, W.A. Solis, Y. Yang, and T.P. Dalton. 2000. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59(1):65-85.

Nelson, K., and L.B. Holmes. 1989. Malformations due to presumed spontaneous mutations in newborn infants. N. Engl. J. Med. 320(1):19-23.

Neubert, R., and D. Neubert. 1997. Peculiarities and possible mode of actions of thalidomide. Pp. 41-119 in Drug Toxicity in Embryonic Development II, Handbook of Experimental Pharmacology, Vol. 124/II, R.J. Kavlock, and G.P. Daston, eds. Heidelberg: Springer.

Neul, J.L., and E.L. Ferguson. 1998. Spatially restricted activation of the SAX receptor by SCW modulates DPP/TKV signaling in Drosophila dorsal-ventral patterning. Cell 95(4):483-494.

Neumann, D.A., and C.A. Kimmel, eds. 1998. Human Variability in Response to Chemical Exposure Measures, Modeling and Risk Assessment. Boca Raton, FL: CRC Press. 257pp.

Newall, D.R., and K.E. Beedles. 1996. The stem-cell test: An in-vitro assay for teratogenic potential. Results of a blind trial with 25 compounds. Toxicol. in Vitro 10(2):229-240.

Newbold, R.R., R.B. Hanson, and W.N. Jefferson. 1997. Ontogeny of lactoferrin in the developing mouse uterus: A marker of early hormone response. Biol. Reprod. 56(5):1147-1157.

Newman, L.M., E.M. Johnson, and R.E. Staples. 1993. Assessment of the effectiveness of animal developmental toxicity testing for human safety. Reprod. Toxicol. 7(4):359-390.

Ng, J.K., K. Tamura, D. Buscher, and J.C. Izpisua-Belmonte. 1999. Molecular and cellular basis of pattern formation during vertebrate limb development. Curr. Top. Dev. Biol. 41:37-66.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Niederreither, K., V. Subbarayan, P. Dolle, and P. Chambon. 1999. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat. Genet. 21(4):444-448.

NIEHS (National Institute of Environmental Health Sciences). 1997. Validation and Regulatory Acceptance of Toxicological Test Methods: A Report of the Ad Hoc Interagency Coordinating Committee on the Validation of Alternative Methods, NIH Pub. No. 97-3981, NIEHS, Research Triangle Park, NC. March.

NIEHS (National Institute of Environmental Health Sciences). 1998. NIEHS News: New NTP Centers Meet the Need to Know. Environ Health Perspect. 106(10). [Online]. Available: http://ehpnet1.niehs.nih.gov/docs/1998/106-10/niehsnews.html.

Nisbet, I.C.T., and N.J. Karch. 1983. Chemical Hazards to Human Reproduction. Noyes Data Corp., Park Ridge, IL.

Nishina, H., K.D. Fisher, L. Radvanyi, A. Shahinian, R. Hakem, E.A. Rubie, A. Bernstein, T.W. Mak, J.R. Woodgett, and J.M. Penninger. 1997. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385(6614):350-353.

Nolen, G.A. 1986. The effects of prenatal retinoic acid on the viability and behavior of the offspring. Neurobehav. Toxicol. Teratol. 8(6):643-654.

NRC (National Research Council). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington DC: National Academy Press.

NRC (National Research Council). 1989. Biologic Markers in Reproductive Toxicology. Washington, DC: National Academy Press.

NRC (National Research Council). 1994. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press.

NRC (National Research Council). 1996. Carcinogens and Anticarcinogens in the Human Diet. Washington, DC: National Academy Press.

Nuclear Receptors Committee. 1999. A unified nomenclature system for the nuclear receptor superfamily. [ Letter]. Cell 97(2):161-163.

Nübler-Jung, K., and D. Arendt. 1996. Enteropneusts and chordate evolution. Curr. Biol. 6(4): 352-353.

Nüsslein-Volhard, C. 1991. Determination of the embryonic axes of Drosophila. Development (Suppl.) 1:1-10.

Nüsslein-Volhard C., and E. Wieschaus. 1980. Mutations affecting segment number and polarity in Drosophila. Nature 287:795-801.

Nuwaysir, E.F., M. Bittner, J. Trent, J.C. Barrett, and C.A. Afshari. 1999. Microarrays and toxicology: The advent of toxicogenomics. Mol. Carcinog. 24(3):153-159.


Oakley, G.P. 1986. Frequency of human congenital malformations. Clin. Perinatol. 13(3):545-554.

OECD (Organization for Economic Cooperation and Development). 1987. OECD Guidelines for the Testing of Chemicals.

OECD (Organization for Economic Cooperation and Development). 1998. OECD Guideline for the Testing of Chemicals. Proposal for Updating Guideline 414. Prenatal Development Toxicity Study. Draft Document. (March 1998).

Oeda, K., T. Sakaki, and H. Ohkawa. 1985. Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae. DNA 4(3):203-210.

O’Flaherty, E. 1997. Pharmacokinetics, pharmacodynamics, and prediction of developmental abnormalities. Reprod. Toxicol. 11(2/3):413-416.

Omenn, G.S., and E.M. Faustman. 1997. Risk assessment, risk communication and risk management. Pp. 969-986 in The Scope of Public Health, Vol.2., Oxford Textbook of Public Health, 3rd Ed., R. Detels, W.W. Holland, J. McEwen, and G.S. Omenn, eds. New York: Oxford University Press.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Ortega, S., M. Ittmann, S.H. Tsang, M. Ehrlich, and C. Basilico. 1998. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. U.S.A. 95(10):5672-5677.

Ou, Y.C., S.A. Thompson, S.C. Kirchner, T.J. Kavanagh, and E.M. Faustman. 1997. Induction of growth arrest and DNA damage-inducible genes Gadd45 and Gadd153 in primary rodent embryonic cells following exposure to methylmercury. Toxicol. Appl. Pharmacol. 147(1):31-38.

Ou, Y.C., S.A. Thompson, R.A. Ponce, J. Schroeder, T.J. Kavanagh, and E.M. Faustman. 1999. Induction of the cell cycle regulatory gene p21 (Waf1, Cip1) following methylmercury exposure in vitro and in vivo. Toxicol. Appl. Pharmacol. 157(3):203-212.

Oudenampsen, E., E.M. Kupsch, T. Wissel, F. Spener, and A. Lezius. 1990. Expression of fatty acid-binding protein from bovine heart in Escherichia coli. Mol. Cell Biochem. 98(1-2):75-79.


Pace, N.R. 1997. A molecular view of microbial diversity and the biosphere. Science 276(5313): 734-740.

Padgett, R.W., P. Das, and S. Krishna. 1998. TGF-beta signaling, Smads, and tumor suppressors. BioEssays 20:382-391.

Park, S., J. Frisen, and M. Barbacid. 1997. Aberrant axonal projections in mice lacking EphA8 (Eek) tyrosine protein kinase receptors. EMBO J. 16(11):3106-3114.

Palmiter, R.D., E.P. Sandgren, M.R. Avarbock, D.D. Allen, and R.L. Brinster. 1991. Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. U.S.A. 88(2): 478-482.

Parker, K.L., A. Schedl, and B.P. Schimmer. 1999. Gene interactions in gonadal development. Annu. Rev. Physiol. 61:417-433.

Parsons, J.F., J. Rockley, and M. Richold. 1990. In-vitro micromass teratogen test- interpretation of results from a blind trial of 25 compounds using 3 separate criteria. Toxicol. in Vitro 4(4-5):609-611.

Payne, J., F. Shibasaki, and M. Mercola. 1997. Spina bifida occulta in homozygous Patch mouse embryos. Dev. Dyn. 209(1):105-116.

Pennisi, E. 1997. A catalog of cancer genes at the click of a mouse. Science 276(5315):1023-1024.

Perera, F.P., R.M. Whyatt, W. Jedrychowski, V. Rauh, D. Manchester, R.M. Santella, and R. Ottman. 1998. Recent developments in molecular epidemiology. A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am. J. Epidem. 147(3): 309-314.

Perrimon, N., and A.P. McMahon. 1999. Negative feedback mechanisms and their roles during pattern formation. Cell 97(1):13-16.

Perrimon, N., L. Engstrom, and A.P. Mahowald. 1989. Zygotic lethals with specific maternal effect phenotypes in Drosophila melanogaster. I. Loci on the X chromosome. Genetics 121:333-352.

Peterka, M., and T. Pexieder. 1994. Embryotoxicity and teratogenicity of all-trans retinoic acid in chick embryo. Teratology 50(5):39A.

Peters, H., and R. Balling. 1999. Teeth. Where and how to make them. Trends Genet. 15(2):59-65.

Peterson, L.A., M.R. Brown, A.J. Carlisle, E.C. Kohn, L.A. Liotta, M.R. Emmert-Buck, and D.B. Krizman. 1998. An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res. 58(23):5326-5328.

Petrini, J., K. Damus, and R.B. Johnston, Jr. 1997. An overview of infant mortality and birth defects in the United States. Teratology 56(1/2):8-9.

Philippe, A., M. Martinez, M. Guilloud-Bataille, C. Gillberg, M. Rastam, E. Sponheim, M. Coleman, M. Zappella, H. Aschauer, L. van Malldergerme, C. Penet, J. Feingold, A. Brice, and M. Leboyer. 1999. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum. Mol. Genet. 8(5):805-812.

Pichel, J.G., L. Shen, H.Z. Sheng, A.C. Granholm, J. Drago, A. Grinberg, E.J. Lee, S.P. Huang, M. Saarma, B.J. Hoffer, H. Sariola, and H. Westphal. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382(6586):73-76.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Pignatello, M.A., F.C. Kauffman, and A.A. Levin. 1999. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): Interactions with the retinoic acid receptors. Toxicol. Appl. Pharmacol. 159(2):109-116.

Plasterk, R.H.A. 1995. Reverse genetics: From gene sequence to mutant worm. Pp. 59-80 in Methods in Cell Biology, Vol. 48, Caenorhabditis elegans: Modern Biological Analysis of an Organism, H.F. Epstein, and D.C. Shakes, eds. San Diego, CA: Academic Press.

Poland, A., D. Palen, and E. Glover. 1994. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46(5):915-921.

Ponce, R.A., T.J. Kavanagh, N.K. Mottet, S.G. Whittaker, and E.M. Faustman. 1994. Effects of methyl mercury on the cell cycle of primary rat CNS cells in vitro. Toxicol. Appl. Pharmacol. 127(1):83-90.

Porter, J.A., K.E. Young, and P.A. Beachy. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274(5285):255-259.

Powell-Braxton, L., P. Hollingshead, C. Warburton, M. Dowd, S. Pitts-Meek, D. Dalton, N. Gillett, and T.A. Stewart. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7(12B):2609-2617.

Powell-Coffman, J.A., C.A. Bradfield, and W.B. Wood. 1998. Caenorhabditis elegans orthologs of the aryl hydrocarbon receptor and its heterodimerization partner the aryl hydrocarbon receptor nuclear translocator. Proc. Natl. Acad. Sci. U.S.A. 95:2844-2849.


Quig, D. 1998. Cysteine metabolism and metal toxicity. Altern. Med. Rev. 3(4):262-270.


Radatz, M., K. Ehlers, B. Yagen, M. Bialer, and H. Nau. 1998. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res. 30(1):41-48.

Raftery, L.A., V. Twombly, K. Wharton, and W.M. Gelbart. 1995. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics 139:241-254.

Rawls, A., J. Wilson-Rawls, and E.N. Olson. 2000. Genetic regulation of somite formation. Curr. Top. Dev. Biol. 47:131-154.

Reiners, J., W. Wittfoht, H. Nau, R. Vogel, B. Tenschert, and H. Spielmann 1987. Teratogenesis and pharmacokinetics of cyclophosphamide after drug infusion as compared to injection in the mouse during day 10 of gestation. Pp. 41-48 in Pharmacokinetics in Teratogenesis, Vol. II, H. Nau, and W. Scott, eds. Boca Raton, FL: CRC Press.

Reinhardt, C.A. 1993. Neurodevelopmental toxicity in vitro: Primary cell culture models for screening and risk assessment [Review]. Reprod. Toxicol. 7(Suppl. 1):165-170.

Reichhardt, T. 1999. It’s sink or swim as a tidal wave of data approaches. Nature 399(6736):517-520.

Relaix, F., and M. Buckingham. 1999. From insect eye to vertebrate muscle: Redeployment of a regulatory network. Genes Dev. 13(24):3171-3178.

Renwick, A.G. 1998. Toxicokinetics in infants and children in relation to the ADI and TDI. Food Addit. Contam. 15(Suppl.):17-35.

Riddle, D.L., and P.S. Albert. 1997. Genetic and environmental regulation of dauer larva development. Pp. 739-768 in C. elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press.

Riddle, D.L., T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. 1997. C. elegans II. Plainview, NY: Cold Spring Harbor Laboratory Press. 1222 pp.

Robert, E. 1992. Detecting new teratogens: Valproic acid. Teratology 45(3):331.

Rodier, P.M. 1998. Neuroteratology of autism. Pp. 661-672 in Handbook of Developmental Neurotoxicology, W. Slikker, and L. Chang, eds. New York: Academic Press.

Rodier, P.M. 2000. The early origins of autism. Sci. Am. 282:56-63.

Rodier, P.M., M. Aschner, and P.R. Sager. 1984. Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. Neurobehav. Toxicol. Teratol. 6(5):379-385.

Rodier, P.M., S.E. Bryson, and J.P. Welch. 1997. Minor malformations and physical measurements in autism: Data from Nova Scotia. Teratology 55(5):319-325.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Rodier, P.M., J.L. Ingram, B. Tisdale, S. Nelson, and J. Romano. 1996. Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370(2):247-261.

Roelink, H., J.A. Porter, C. Chiang, Y. Tanabe, D.T. Chang, P.A. Beachy, and T.M. Jessell. 1995. Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81(3):445-455.

Rosa, F.W. 1992. Epidemiology of drugs in pregnancy. Pp. 97-106 in Pediatric Pharmacology, 2nd Ed., S.J. Yaffe, and J.V. Aranda, eds. Philadelphia, PA: Saunders.

Rothman, K.J. 1986. Modern Epidemiology. Boston: Little, Brown.

Roux, C., and M. Aubry. 1966. Teratogenic action in the rat of an inhibitor of cholesterol synthesis, AY 9944 [in French]. C. R. Seances Soc. Biol. Fil. 160(7):1353-1357.

Rudner, A.D., and A.W. Murray. 1996. The spindle assembly checkpoint. Curr. Opin. Cell Biol. 8(6):773-780.

Rutherford, S.L., and S. Lindquist. 1998. Hsp90 as a capacitor for morphological evolution. Nature 396(6709):336-342.

Rutledge, J.C. 1997. Developmental toxicity induced during early stages of mammalian embryogenesis. Mutat. Res. 396(1-2):113-127.

Rutledge, J.C., A.G. Shourbaji, L.A. Hughes, J.E. Polifka, Y.P. Cruz, J.B. Bishop, and W.M. Generoso. 1994. Limb and lower-body duplications induced by retinoic acid in mice. Proc. Natl. Acad. Sci. U.S.A. 91(12):5436-5440.

Ruvkun, G. 1997. Patterning the nervous system. Pp. 543-581 in C. elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press.

Ruvkun, G., and O. Hobert. 1998. The taxonomy of developmental control in Caenorhabditis elegans. Science 282(5396):2033-2041.


Saint-Amant, L., and P. Drapeau. 1998. Time course of the development of motor behaviors in the zebrafish embryo. J. Neurobiol. 37(4):622-632.

Salvesen, G.S. 1999. Programmed cell death and the caspases. APMIS 107(1):73-79.

Sanchez, M.P., I. Silos-Santiago, J. Frisen, B. He, S.A. Lira, and M. Barbacid. 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF . Nature 382(6586):70-73.

Sanford, L.P., I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, G.P. Boivin, E.L. Cardell, and T. Doetschman. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124(13):2659-2670.

Sariola, H., and K. Sainio. 1998. Cell lineages in the embryonic kidney: Their inductive interactions and signalling molecules. Biochem. Cell Biol. 76(6):1009-1016.

Saxton, T.M., M. Henkemeyer, S. Gasca, R. Shen, D.J. Rossi, F. Shalaby, G.S. Feng, and T. Pawson. 1997. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16(9):2352-2364.

Schardein, J.L. 2000. Chemically Induced Birth Defects, 3th Ed. New York: Marcel Dekker.

Schilling, T.F., T. Piotrowski, H. Grandel, M. Brand, C.P. Heisenberg, Y.J. Jiang, D. Beuchle, M. Hammerschmidt, D.A. Kane, M.C. Mullins, F.J. van Eeden, R.N. Kelsh, M. Furutani-Seiki, M. Granato, P. Haffter, J. Odenthal, R.M. Warga, T. Trowe, and C. Nüsslein-Volhard. 1996. Jaw and branchial arch mutants in zebrafish I: branchial arches. Development 123:329-344.

Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birshmeier. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373(6516):699-702.

Schneider, R.A., D. Hu, and J.A. Helms. 1999. From head to toe: Conservation of molecular signals regulating limb and craniofacial morphogenesis. Cell Tissue Res. 296(1):103-109.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Schuchardt, A., V. D’Agati, L. Larsson-Blomberg, F. Costantini, and V. Pachnis. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367(6461):380-383.

Schuchardt, A., V. D’Agati, V. Pachnis, and F. Costantini. 1996. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 122(6): 1919-1929.

Schwartz, E.L., S. Hallam, R.E. Gallagher, and P.H. Wiernik. 1995. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem. Pharmacol. 50(7):923-928.

Schwetz, B.A. 1993. In vitro approaches in developmental toxicology. [Review]. Reprod. Toxicol. 7(Suppl. 1):125-127.

Schwetz, B.A., and M.W. Harris. 1993. Developmental toxicology: Status of the field and contribution of the National Toxicology Program. [Review]. Environ. Health Perspect. 100:269-282.

Scott, W.J. 1977. Cell death and reduced proliferation rate. Pp. 81-98 in Handbook of Teratology, Vol. 2., J.G. Wilson, and F.C. Fraser, eds. New York: Plenum.

Selevan, S.G. 1985. Design of pregnancy outcome studies of industrial exposures. Pp. 219-229 in Occupational Hazards and Reproduction, K. Hemminki, M. Sorsa, and H. Vainio, eds. Washington, DC: Hemishere Pub.

Sever, L., M.C. Lynberg, and L.D. Edmonds. 1993. The impact of congenital malformations on public health. Teratology 48(6):547-549.

Shaw, G.M., C.R. Wasserman, E.J. Lammer, C.D. O’Malley, J.C. Murray, A.M. Basart, and M.M. Tolarova. 1996. Orofacial clefts, parental cigarette smoking and transforming growth factor-alpha gene variants. Am. J. Hum. Genet. 58:551-561.

Shepard, T.H. 1998. Catalog of Teratogenic Agents. 9th Ed. Baltimore: Johns Hopkins University Press. 593 pp.

Shepard, T.H., A.G. Fantel, P.E. Mirkes, J.C. Greenaway, E. Faustman-Watts, M. Campbell, and M.R. Juchau. 1983. Teratology testing: I. Development and status of short-term prescreens. II. Biotransformation of teratogens as studied in whole embryo culture. Prog. Clin. Biol. Res. 135:147-164.

Shuey, D.L., R.W. Setzer, C. Lau, R.M. Zucker, K.H. Elstein, M.G. Narotsky, R.J. Kavlock, and J.M. Rogers. 1995. Biological modeling of 5-fluorouracil developmental toxicity. Toxicology 102(1-2):207-213.

Shum, S., N.M. Jensen, and D.W. Nebert. 1979. The murine Ah locus: In utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. Teratology 20(3): 365-376.

Sibilia, M., and E.F. Wagner. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269(5221):234-238.

Sidrauski, C., R. Chapman, and P. Walter. 1998. The unfolded protein response: An intracellular signalling pathway with many surprising features. Trends Cell. Biol. 8(6):245-249.

Silver, L.M. 1995. Mouse Genetics: Concepts and Applications. New York: Oxford University Press. 362pp.

Simone, N.L., R.F. Bonner, J.W. Gillespie, M.R. Emmert-Buck, and L.A. Liotta. 1998. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet. 14(7):272-276.

Simon, M.A., D.D. Bowtell, G.S. Dodson, T.R. Laverty, and G.M. Rubin. 1991. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell 67(4):701-716.

Sleet, R.B., and K. Brendel. 1985. Homogeneous populations of Artemia nauplii and their potential use for in vitro testing in developmental toxicology. Teratog. Carcinog. Mutagen. 5(1):41-54.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Slikker, W., and R.K. Miller. 1994. Placental metabolism and transfer, role in developmental toxicology. Pp. 245-283 in Developmental Toxicology, 2nd Ed., C. Kimmel, and J. Buelke-Sam, eds. New York: Raven Press.

Smeyne, R.J., R. Klein, A. Schnapp, L.K. Long, S. Bryant, A. Lewin , S.A. Lira, and M. Barbacid. 1994. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368(6468):246-249.

Smith, J.L., and G.C. Schoenwolf. 1998. Getting organized: New insights into the organizer of higher vertebrates. Curr. Top. Dev. Biol. 40:79-110.

Smith, M.K., G.L. Kimmel, D.M. Kochhar, T.H. Shepard, S.P. Spielberg, and J.G. Wilson. 1983. A selection of candidate compounds for in vitro teratogenesis test validation. Teratog. Carcinog. Mutagen. 3(6):461-480.

Snow, E.T. 1997. The role of DNA repair in development. Reprod. Toxicol. 11(2/3):353-365.

Soriano, P. 1997. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 124(14):2691-2700.

Spellman, P.T., G. Sherlock, M.Q. Zhang, V.R. Iyer, K. Anders, M.B. Eisen, P.O. Brown, D. Botstein, and B. Futcher. 1998. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell 9(12):3273-3297.

Spemann, H., and H. Mangold. 1924. Über Induktion von Embryonalanlagen durch Implatation artfremder Organisatoren. [in German]. Arch. f. Mikr. Anat. u. Entw.-Mech. 100:599-638.

Spence, S., C. Anderson, M. Cukierski, and D. Patrick. 1999. Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod. Toxicol. 13(1):15-29.

Spiegelstein, O., M. Bialer, M. Radatz, H. Nau, and B. Yagen. 1999. Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid. Chirality 11(8):645-650.

Spielmann, H., I. Pohl, B. Doring, M. Liebsch, and F. Moldenhauer. 1997. The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicol. 10(1):119-127.

Spielmann, H., G. Scholtz, A. Seiler, I. Pohl, S. Bremer, N. Brown, and A. Piersma. 1998. Ergebnisse der ersten Phase des ECVAM-Projektes zur Prävalidierung und Validierung von drei in vitro Embryotoxizitätstests. [in German]. ALTEX 15:3-8.

Stainier, D.Y., and M.C. Fishman. 1992. Patterning the zebrafish heart tube: Acquisition of anteroposterior polarity. Dev. Biol. 153(1):91-101.

Stainier, D.Y., B. Fouquet, J.N. Chen, K.S. Warren, B.M. Weinstein, S.E. Meiler, M.A. Mohideen, S.C. Neuhauss, L. Solnica-Krezel, A.F. Schier, F. Zwartkruis, D.L. Stemple, J. Malicki, W. Driever, and M.C. Fishman. 1996. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 123:285-292.

Stearnes, S.C. 1989. The evolutionary significance of phenotypic plasticity. Bioscience 39(7): 436-445.

Steele, V.E., R.E. Morrissey, E.L. Elmore, D. Gurganus-Rocha, B.P. Wilkinson, R.D. Curren, B.S. Schmetter, A.T. Louie, J.C. Lamb, IV, and L.L. Yang. 1988. Evaluation of two in vitro assays to screen for potential developmental toxicants. Fundam. Appl. Toxicol. 11(4):673-684.

Stephens, T.D. 1988. Proposed mechanisms of action in thalidomide embryopathy. Teratology 38(3):229-239.

Stephens, T.D., and B.J. Fillmore. 2000. Hypothesis: Thalidomide embryopathy—proposed mechanism of action. Teratology 61(3):189-195.

Sternberg, P.W., and H.R. Horvitz. 1991. Signal transduction during C. elegans vulval induction. Trends Genet. 7(11/12):366-371.

Stodgell, C.J., L.L. Knauber, J.L. Ingram, S.L. Hyman, D.A. Figlewicz, and P.M. Rodier. 1999. A structural variant of HOXA1 associated with autism. [Abstract]. Teratology 59:389.

Stohs, S.J., and D. Bagchi. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18(2):321-336.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

St-Onge, L., R. Wehr, and P. Gruss. 1999. Pancreas development and diabetes. Curr. Opin. Genet. Dev. 9(3):295-300.

Storm, E.E., and D.M. Kingsley. 1996. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122(12):3969-3979.

Streissguth, A.P., and P. Dehaene. 1993. Fetal alcohol syndrome in twins of alcoholic mothers: Concordance of diagnosis and IQ. Am. J. Med. Genet. 47(6):857-861.

Strom, B.L., ed. 1994. Systems available for pharmacoepidemiology studies. Pp 125-337 in Pharmacoepidemiology, 2nd Ed. New York: John Wiley & Sons.

Strömland, K., V. Nordin, M. Miller, B. Akerstrom, and C. Gillberg. 1994. Autism in thalidomide embryopathy: A population study. Dev. Med. Child Neurol. 36(4):351-356.

Studer, M., A. Lumsden, L. Ariza-McNaughton, A. Bradley, and R. Krumlauf. 1996. Altered segmental identity and abnormal migration of motor neurons in mice lacking Hoxb-1. Nature 384(6610):630-634.

Sucov, H.M., E. Dyson, C.L. Gumeringer, J. Price, K.R. Chien, and R.M. Evans. 1994. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8(9):1007-1018.

Sucov, H.M., J.C. Izpisua-Belmonte, Y. Ganan, and R.M. Evans. 1995. Mouse embryos lacking RXR alpha are resistant to retinoic-acid-induced limb defects. Development 121(12):3997-4003.

Sugrue, S.P., and J.M. DeSesso. 1982. Altered glycosaminoglycan composition of rat forelimb-buds during hydroxyurea teratogenesis: An indication of repair. Teratology 26(1):71-83.

Sullivan, F.M., S.E. Smith, and P.R. McElhatton 1987. Interpretation of animal experiments as illustrated by studies on caffeine. Pp.123-130 in Pharmacokinetics in Teratogenesis, Vol. I. Interspecies Comparison and Maternal/Embryonic-Fetal Drug Transfer, H. Nau, and W. Scott, eds. Boca Raton, FL: CRC Press.

Sulston, J.E., and H.R. Horvitz. 1977. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev. Biol. 56(1):110-156.

Sulston, J.E., E. Schierenberg, J.G. White, and J.N. Thomson. 1983. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol. 100:64-119.

Summerbell, D., and P.W. Rigby. 2000. Transcriptional regulation during somitogenesis. Curr. Top. Dev. Biol. 48:301-318.

Suzuki, Y., M.D. Yandell, P.J. Roy, S. Krishna, C. Savage-Dunn, R.M. Ross, R.W. Padgett, and W.B. Wood. 1999. A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans. Development 126(2):241-250.

Swain, A., and R. Lovell-Badge. 1999. Mammalian sex determination: A molecular drama. Genes Dev. 13(7):755-767.

Swiatek, P.J., C.E. Lindsell, F.F. del Amo, G. Weinmaster, and T. Gridley. 1994. Notch1 is essential for postimplantation development in mice. Genes Dev. 8(6):707-719.


Tabin, C.J. 1998. A developmental model for thalidomide defects. Nature 396(6709):322-323.

Takahashi, J.S. 1995. Molecular neurobiology and genetics of circadian rhythms in mammals. Annu. Rev. Neurosci. 18:531-553.

Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94(8):3801-3804.

Tallquist, M.D., P. Soriano, and R.A. Klinghoffer. 1999. Growth factor signaling pathways in vascular development. Oncogene 18(55):7917-7932.

Tamayo, P., D. Slonim, J. Mesirov, Q. Zhu, S. Kitareewan, E. Dmitrovsky , E.S. Lander, and T.R. Golub. 1999. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. U.S.A. 96(6):2907-2912.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Tanabe, Y., and T.M. Jessell. 1996. Diversity and pattern in the developing spinal cord. Science 274(5290):1115-1123.

Taubes, G. 1995. Epidemiology faces its limits. Science 269:164-169.

Terry, K.K., B.A. Elswick, D.B. Stedman, and F. Welsch. 1994. Developmental phase alters dosimetry-teratogenicity relationship for 2-methoxyethanol in CD-1 mice. Teratology 49:218-227.

Threadgill, D.W., A.A. Dlugosz, L.A. Hansen, T. Tennenbaum, U. Lichti, D. Yee, C. LaMantia, T. Mourton, K. Herrup, R.C. Harris, et al. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269(5221):230-234.

Tillner, J., T. Winckler, and T. Dingermann. 1996. Developmentally regulated promoters from Dictyostelium discoideum as molecular markers for testing potential teratogens. Pharmazie. 51(11):902-906.

Tint, G.S., M. Irons, E.R. Elias, A.K. Batta, R. Frieden, T.S. Chen, and G. Salen. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330(2):107-113.

Toraason, M., J.S. Bohrman, E. Krieg, R.D. Combes, S.E. Willington, W. Zajac, and R. Langenbach. 1992. Evaluation of the V79 cell metabolic cooperation assay as a screen in vitro for developmental toxicants. Toxicol. in Vitro 6(2):165-174.

Treinen, K.A., C. Louden, M.J. Dennis, and P.J. Wier. 1999. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. Teratology 59(1):51-59.

Trofimova-Griffin, M.E., M.R. Brzezinski, and M.R. Juchau. 2000. Patterns of CYP26 expression in human prenatal cephalic and hepatic tissues indicate an important role during early brain development. Brain Res. Dev. Brain Res. 120(1):7-16.

Tucker, A.S., and P.T. Sharpe. 1999. Molecular genetics of tooth morphogenesis and patterning: The right shape in the right place. J. Dent. Res. 78(4):826-834.

Turner, M., P.J. Mee, A.E. Walters, M.E. Quinn, A.L. Mellor, R. Zamoyska, and V.L. Tybulewicz. 1997. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7(4):451-460.

Tzimas, G., R. Thiel, I. Chahoud, and H. Nau. 1997. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat. Toxicol. Appl. Pharmacol. 143:436-444.


Umanoff, H., W. Edelmann, A. Pellicer, and R. Kucherlapati. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. U.S.A. 92(5):1709-1713.

Uphill, P.F., S.R. Wilkins, and J.A. Allen. 1990. In vitro Micromass Teratogen Test - results from a blind trial of 25 compounds. Toxicol. in Vitro 4(4-5):623-626.


Vaglia, J.L., and B.K. Hall. 1999. Regulation of neural crest cell populations: Occurrence, distribution and underlying mechanisms. Int. J. Dev. Biol. 43(2):95-110.

Van den Berg, M., L. Birnbaum, A.T.C. Bosveld, B. Brunstrom, P. Cook, M. Feeley, J.P. Giesy, A. Hanberg, R. Hasegawa, S.W. Kennedy, T. Kubiak, J.C. Larsen, F.X. van Leeuwen, A.K. Liem, C. Nolt, R.E. Peterson, L. Poellinger, S. Safe, D. Schrenk, D. Tillitt, M. Tysklind, M. Younes, F. Waern, and T. Zacharewski. 1998. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 106(12):775-792.

van Dyke, D.C., S.E. Hodge, F. Heide, and L.R. Hill. 1988. Family studies in fetal phenytoin exposure. J. Pediatr. 113(2):301-306.

Vanden Bossche, H., G. Willemsens, and P.A. Janssen. 1988. Cytochrome-P-450-dependent metabolism of retinoic acid in rat skinmicrosomes: Inhibition by ketoconazole. Skin Pharmacol. 1(3):176-185.

Vasicek, T.J., L. Zeng, X.J. Guan, T. Zhang, F. Costantini, and S.M. Tilghman. 1997. Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics 147(2): 777-786.

Velie, E.M., and G.M. Shaw. 1996. Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am. J. Epidemiol. 144(5):473-479.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Ventura, S.J., J.A. Martin, S.C. Curtin, and T.J. Matthews. 1997. Report of Final Natality Statistics. Hyattsville, MD: U.S. Department of Health and Human Services, CDC, National Center for Health Statistics, 45(11) Suppl. 2. PHS 97-1120.

Veraksa, A., M. Del Campo, and W. McGinnis. 2000. Developmental patterning genes and their conserved functions: From model organisms to humans. Mol. Genet. Metab. 69(2):85-100.

Vogel, D.G., P.S. Rabinovitch, and N.K. Mottet. 1986. Methylmercury effects on cell cycle kinetics. Cell Tissue Kinet. 19(2):227-242.

Vogt, T.F., and D. Duboule. 1999. Antagonists go out on a limb. Cell 99(6):563-566.


Waitzman, N.J., P.S. Romano, and R.M. Scheffler. 1994. Estimates of the economic costs of birth defects. Inquiry 31(2):188-205.

Wakayama, T., and R. Yanagimachi. 1999a. Cloning of male mice from adult tail-tip cells. Nat. Genet. 22(2):127-128.

Wakayama, T., and R. Yanagimachi. 1999b. Cloning the laboratory mouse. Semin. Cell Dev. Biol. 10(3):253-258.

Wakayama, T., A.C. Perry, M. Zuccotti, K.R. Johnson, and R. Yanagimachi. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394(6691): 369-374.

Wakayama, T., I. Rodriguez, A.C. Perry, R. Yanagimachi, and P. Mombaerts. 1999. Mice cloned from embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 96(26):14984-14989.

Walker, B.E., and M.I. Haven. 1997. Intensity of multigenerational carcinogenesis from diethylstilbestrol in mice. Carcinogenesis 18(4):791-793.

Walmod, P.S., A. Foley, A. Berezin, U. Ellerbeck, H. Nau, E. Bock, and V. Berezin. 1998. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues . Cell Motil. Cytoskeleton 40(3):220-237.

Walmod, P.S., G. Skladchikova, A. Kawa, V. Berezin, and E. Bock. 1999. Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton. Cell Motil. Cytoskeleton. 42(3):241-255.

Walton, B.T. 1983. Use of the cricket embryo (Acheta domesticus) as an invertebrate teratology model. Fundam. Appl. Toxicol. 3(4):233-236.

Wang, Y.L., and N.A. Brown. 1994. Expression patterns of Hox-B1, -B2 and Krox 20 in triazole-treated rat embryos suggest rhombomere reductions and loss. Teratology 49:380.

Wang, Z.Q., M.R. Fung, D.P. Barlow, and E.F. Wagner. 1994. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372(6505):464-467.

Wang, Z.Q., C. Ovitt, A.E. Grigoriadis, U. Mohle-Steinlein, U. Ruther, and E.F. Wagner. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature 360(6406):741-745.

Warburton, D., and M.K. Lee. 1999. Current concepts on lung development. Curr. Opin. Pediatr. 11(3):188-192.

Warkany, J. 1978. Teratogen update: Aminopterin and methotrexate. Folic acid deficiency. Teratology 17(Jan.):353-358.

Wassef, M., and A.L. Joyner. 1997. Early mesencephalon/metencephalon patterning and development of the cerebellum. Perspect. Dev. Neurobiol. 5(1):3-16.

Wasteneys, G.O., M. Cadrin, K.R. Reuhl, and D.L. Brown. 1988. The effects of methylmercury on the cytoskeleton of murine embryonal carcinoma cells. Cell Biol. Toxicol. 4(1):41-60.

Webster, W.S., P.D. Brown-Woodman, and H.E. Ritchie. 1997. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing. Int. J. Dev. Biol. 41(2):329-335.

Webster, W.S., P.D. Brown-Woodman, M.D. Snow, and B.R. Danielsson. 1996. Teratogenic potential of almokalant, dofetilide, and d-sotalol: Drugs with potassium channel blocking activity. Teratology 53(3):168-175.

Weiner, A.J., M.P. Scott, and T.C. Kaufman. 1984. A molecular analysis of fushi tarazu, a gene in Drosophila melanogaster that encodes a product affecting embryonic segment number and cell fate. Cell 37(3):843-851.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Weinstein, D.C., and A. Hemmati-Brivanlou. 1999. Neural induction. Annu. Rev. Cell. Dev. Biol. 15:411-433.

Weinstein, M., X. Xu, K. Ohyama, and C.X. Deng. 1998. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125(18):3615-3623.

Weiss, S.R., C.E. Cooke, L.R. Bradley, and J.M. Manson. 1999. Pharmacist’s guide to pregnancy registry studies. J. Am. Pharm. Assoc. 39(6):830-834.

Welch, R.M., Y.E. Harrison, B.W. Gommi, P.J. Poppers, M. Finster, and A.H. Conney. 1969. Stimulatory effect of cigarette smoking on the hydroxylation of 3,4-benzo(a)pyrene and the N-demethylation of 3-methyl-4-monomethylamino-azobenzene by enzymes in human placenta. Clin. Pharm. Therap. 10(1):100-110.

Welch, W.J. 1991. The role of heat-shock proteins as molecular chaperones. Curr. Opin. Cell Biol. 3(6):1033-1038.

Weller, E., N. Long, A. Smith, P. Williams, S. Ravi, J. Gill, R. Henessey, W. Skornik, J. Brain, C. Kimmel, G. Kimmel, L. Holmes, and L. Ryan. 1999. Dose-rate effects of ethylene oxide exposure on developmental toxicity. Toxicol. Sci. 50(2):259-270.

Wellfelt, K., A.C. Skold, A. Wallin, and B.R. Danielsson. 1999. Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species. Reprod. Toxicol. 13(2):93-101.

Wells, P.G., and L.M. Winn. 1996. Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Mol. Biol. 31(1):1-40.

Wells, P.G., P.M. Kim, C.J. Nicol, T. Parman, and L.M. Winn. 1997. Reactive intermediates. Pp. 451-516 in Drug Toxicity in Embryonic Development, Vol 1., Handbook of Experimental Pharmacology , Vol. 124/I, R.J. Kavlock, and G.P. Daston, eds. Heidelberg: Springer.

Wells, P.G, J.T. Zubovits, S.T. Wong, L.M. Molinari, and S. Ali. 1989. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: Implications for bioactivation by prostaglandin synthetase. Toxicol. Appl. Pharmacol. 97(2):192-202.

Welsch, F. 1992. In vitro approaches to the elucidation of mechanisms of chemical teratogenesis. [Review]. Teratology 46(1):3-14.

Welsch, F., G.M. Blumenthal, and R.B. Conolly. 1995. Physiologically based pharmacokinetic models applicable to organogenesis: Extrapolation between species and potential use in prenatal toxicity risk assessments. Toxicol. Lett. 82/83:539-547.

Welsch, F., K.K. Terry, D.B. Stedman, and B.A. Elswick. 1996. Linking embryo dosimetry and teratogenic responses to 2-methoxyethanol at different stages of gestation in mice. Occupat. Hyg. 2:121-130.

Wilcox, A.J., D.D. Baird, and C.R. Weinberg. 1999. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med. 340(23):1796-1799.

Willhite, C.C., P.J. Wier, and D.L. Berry. 1989. Dose response and structure-activity considerations in retinoid-induced dysmorphogenesis. Crit. Rev. Toxicol. 20(2):113-135.

Wilmut, I., A.E. Schnieke, J. McWhir, A.J. Kind, and K.H. Campbell. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385(6619):810-813.

Wilson, C.L., and S. Safe. 1998. Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol. Pathol. 26(5):657-671.

Wilson, J.G. 1973. Environment and Birth Defects. New York: Academic Press. 305 pp.

Wilson, J.G., and F.C. Fraser. 1977. Handbook of Teratology. New York: Plenum Press.

Wilson, K.L., L.M. Cornel, and P.E. Mirkes. 1999. Teratogen-induced activation of mitogen-activated protein kinases (MARKs) in postimplantation embryos. Teratology 59:385-386.

Winter, R.M. 1996. Analysing human developmental abnormalities. Bioessays 18(12):965-971.

Wise, L.D., R.L. Clark, J.O. Rundell, and R.T. Robertson. 1990. Examination of a rodent limb bud micromass assay as a prescreen for developmental toxicity. Teratology 41(3):341-351.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

Wlodarczyk, B.C., J.C. Craig, G.D. Bennett, J.A. Calvin, and R.H. Finnell. 1996. Valproic acid-induced changes in gene expression during neurulation in a mouse model. Teratology 54(6):284-297.

Wolpert, L. 1969. Positional information and the spatial pattern of cellular differentiation. J. Theor. Biol. 25(1):1-47.

Wolpert, L., R. Beddington, J. Brockes, T. Jessell, P. Lawrence, and E. Mayerowitz. 1998. P. 484 in Principles of Development. New York: Current Biology.

Wood, W.B. 1998. Cell lineages in Caenorhabditis elegans development. Pp. 77-95 in Cell Lineage and Fate Determination, S.A. Moody, ed. San Diego, CA: Academic Press.

Wood, W.B. 1999. Caenorhabditis. Pp. 324 in Encyclopedia of Molecular Biology, T.E. Creighton, ed. New York: Wiley.

Wood, W. B. et al., eds. 1988. The Nematode Caenorhabditis elegans. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 667 pp.

Wubah, J.A., M.M. Ibrahim, X. Gao, D. Nguyen, M.M. Pisano, and T.B. Knudsen. 1996. Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr. Biol. 6(1):60-69.

Wubah, J.A., C.A. Kimmel, G.L. Kimmel, R.J. Kavlock, C. Lau, R.W. Setzer, and T.B. Knudsen. 1997. Pax6 expression, a biomarker of teratogen-induced abnormalities of the eye. Teratology 55(1):33.


Xu, T., and S. Artavanis-Tsakonas. 1990. Deltex, a locus interacting with the neurogenic genes, Notch, Delta and mastermind in Drosophila melanogaster. Genetics 126:665-677.

Xu, T., and G.M. Rubin. 1993. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117:1223-1237.


Yacobi, A., J.P. Skelly, V.P. Shah, and L.Z. Benet, eds. 1993. Integration of Pharmacokinetics, Pharmacodynamics and Toxicokinetics in Rational Drug Development. New York: Plenum Press. 270 pp.

Yamaguchi, T.P., K. Harpal, M. Henkemeyer, and J. Rossant. 1994. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 8(24):3032-3044.

Yang, D.D., C.Y. Kuan, A.J. Whitemarsh, M. Rincon, T.S. Zheng, R.J. Davis, P. Rakic, and R.A. Flavell. 1997b. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389(6653):865-870.

Yang, D., C. Tournier, M. Wysk, H.T. Lu, J. Xu, R.J. Davis, and R.A. Flavell. 1997a. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. U.S.A. 94(7):3004-3009.

Yates, J.R. III. 1998. Mass spectrometry and the age of the proteome. J. Mass Spectrom. 33:1-19.


Zakeri, Z., D. Quaglino, and H.S. Ahuja. 1994. Apoptotic cell death in the mouse limb and its suppression in the hammertoe mutant. Dev. Biol. 165(1):294-297.

Zeng, L., F. Fagotto, T. Zhang, W. Hsu, T.J. Vasicek, W.L. Perry, III, J.J. Lee, S.M. Tilghman, B.M. Gumbiner, and F. Costantini. 1997. The mouse fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90(1):181-192.

Zhao, F., K. Mayura, R.W. Hutchinson, R.P. Lewis, R.C. Burghardt, and T.D. Phillips. 1995. Developmental toxicity and structure-activity relationships of chlorophenols using human embryonic palatal mesenchymal cells. Toxicol. Lett. 78(1):35-42.

Zinaman, M.J., E.D. Clegg, C.C. Brown, J. O’Connor, and S.G. Selevan. 1996. Estimates of human fertility and pregnancy loss. Fertil. Steril. 65(3):503-509.

Zuber, M.X., E.R. Simpson, and M.R. Waterman. 1986. Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science 234(4781):1258-1261.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×

This page intentionally left blank.

Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 245
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 246
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 247
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 248
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 249
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 250
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 251
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 252
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 253
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 254
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 255
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 256
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 257
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 258
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 259
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 260
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 261
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 262
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 263
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 264
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 265
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 266
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 267
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 268
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 269
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 270
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 271
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 272
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 273
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 274
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 275
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 276
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 277
Suggested Citation:"References." National Research Council. 2000. Scientific Frontiers in Developmental Toxicology and Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/9871.
×
Page 278
Next: Appendix A Glossary »
Scientific Frontiers in Developmental Toxicology and Risk Assessment Get This Book
×
Buy Hardback | $69.00 Buy Ebook | $54.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Scientific Frontiers in Developmental Toxicology and Risk Assessment reviews advances made during the last 10-15 years in fields such as developmental biology, molecular biology, and genetics. It describes a novel approach for how these advances might be used in combination with existing methodologies to further the understanding of mechanisms of developmental toxicity, to improve the assessment of chemicals for their ability to cause developmental toxicity, and to improve risk assessment for developmental defects. For example, based on the recent advances, even the smallest, simplest laboratory animals such as the fruit fly, roundworm, and zebrafish might be able to serve as developmental toxicological models for human biological systems. Use of such organisms might allow for rapid and inexpensive testing of large numbers of chemicals for their potential to cause developmental toxicity; presently, there are little or no developmental toxicity data available for the majority of natural and manufactured chemicals in use. This new approach to developmental toxicology and risk assessment will require simultaneous research on several fronts by experts from multiple scientific disciplines, including developmental toxicologists, developmental biologists, geneticists, epidemiologists, and biostatisticians.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!